Indiana
|
35-1160484
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
Two Prudential Plaza, Suite 4100
Chicago, IL
|
60601
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of Each Class
|
Name of Each Exchange on Which Registered
|
Common Stock, without par value
|
New York Stock Exchange
|
|
Page
|
|
PART I
|
||
3
|
||
Item 1. |
3
|
|
Item 1A. |
9
|
|
Item 1B. |
14
|
|
Item 2. |
15
|
|
Item 3. |
16
|
|
Item 4. |
16
|
|
PART II
|
||
Item 5. |
17
|
|
Item 6. |
19
|
|
Item 7. |
20
|
|
Item 7A. |
40
|
|
Item 8. |
41
|
|
Item 9. |
80
|
|
Item 9A. |
80
|
|
Item 9B. |
80
|
|
PART III
|
||
Item 10. |
81
|
|
Item 11. |
81
|
|
Item 12. |
81
|
|
Item 13. |
81
|
|
Item 14. |
81
|
|
PART IV
|
||
Item 15. |
82
|
|
84
|
|
·
|
North America -
sells and rents our patient support and near-patient technologies and services, as well as our clinical workflow solutions, in the U.S. and Canada.
|
|
·
|
Surgical and Respiratory Care -
sells and rents our surgical and respiratory care products globally
.
|
|
·
|
International -
sells and rents similar products as our North America segment in regions outside of the U.S. and Canada.
|
Product Categories
|
Competitors | ||
Advancing Mobility
|
ArjoHuntleigh (Division of Getinge AB)
Guldmann
Invacare
Joerns Healthcare
|
Linet
Stiegelmeyer
Stryker Corporation
|
|
Wound Care and Prevention
|
ArjoHuntleigh (Division of Getinge AB)
Freedom Medical, Inc.
RecoverCare, LLC/Joerns Healthcare
|
SIZEWise Rentals, LLC
Universal Hospital Services, Inc.
|
|
Clinical Workflow
|
Ascom Holding
Covidien, Ltd.
Exergen Corporation
GE Healthcare
Heine Optotechnik
|
Omron Healthcare
Philips
Rauland-Borg Corporation
Riester
|
|
Surgical Safety and Efficiency
|
Action Medical
DeRoyal
Draeger
Maquet (Division of Getinge AB)
MizuhoOSI
|
Skytron
Steris
Stryker Corporation
Swann-Morton
|
|
Respiratory Health
|
Electromed, Inc.
Respironics (Division of Philips)
Respirtech
|
·
|
managing a larger combined company;
|
·
|
consolidating corporate and administrative infrastructures;
|
·
|
issues in integrating manufacturing, warehouse and distribution facilities, research and development and sales forces;
|
·
|
difficulties attracting and retaining key personnel;
|
·
|
loss of customers and suppliers and inability to attract new customers and suppliers;
|
·
|
unanticipated issues in integrating information technology, communications and other systems;
|
·
|
incompatibility of purchasing, logistics, marketing, administration and other systems and processes; and
|
·
|
unforeseen and unexpected liabilities related to the merger or Welch Allyn’s business.
|
|
·
|
require us to dedicate a large portion of its cash flow from operations to the servicing and repayment of its debt, thereby reducing funds available for working capital, capital expenditures, research and development expenditures and other general corporate requirements;
|
|
·
|
limit our ability to obtain additional financing to fund future working capital, capital expenditures, research and development expenditures and other general corporate requirements;
|
|
·
|
limit our flexibility in planning for, or reacting to, changes in its business and the industry in which we operate;
|
|
·
|
restrict our ability to make strategic acquisitions or dispositions or to exploit business opportunities;
|
|
·
|
place us at a competitive disadvantage compared to competitors that have less debt;
|
|
·
|
adversely affect our credit rating, with the result that the cost of servicing our indebtedness might increase;
|
|
·
|
adversely affect the market price of Hill-Rom common stock; and
|
|
·
|
limit our ability to apply proceeds from an offering or asset sale to purposes other than the servicing and repayment of debt.
|
Location
|
Description and Primary Use
|
Owned/Leased
|
Acton, MA
|
Light manufacturing, development and distribution of health care equipment;
Office administration
|
Leased
|
Batesville, IN
|
Manufacturing, development and distribution of health care equipment;
Office administration
|
Owned
|
Beaverton, OR
|
Development of heath care equipment;
Office administration
|
Leased
|
Caledonia, MI
|
Manufacturing, development and distribution of surgical products;
Office administration
|
Leased
|
Carol Stream, IL
|
Manufacturing, development and distribution of health care equipment;
Office administration
|
Leased
|
Cary, NC
|
Development of health care equipment;
Office administration
|
Leased
|
Charleston, SC
|
Light manufacturing and distribution of health care equipment;
Office administration
|
Owned/Leased
|
Chicago, IL
|
Office administration
|
Leased
|
St. Paul, MN
|
Office administration
|
Leased
|
Skaneateles Falls, NY
|
Manufacturing, development and distribution of health care equipment;
Office administration
|
Owned
|
Jiangsu, China
|
Manufacturing of health care equipment
|
Leased
|
Taicang, China
|
Light manufacturing and distribution of health care equipment
|
Leased
|
Montpellier, France
|
Manufacturing and development of health care equipment
|
Owned
|
Pluvigner, France
|
Manufacturing, development and distribution of health care equipment;
Office administration
|
Owned
|
Hainichen, Germany*
|
Manufacturing and distribution of health care equipment
|
Owned
|
Puchheim, Germany
|
Manufacturing and distribution of health care equipment
|
Owned
|
Saalfeld, Germany
|
Manufacturing, development and distribution of health care equipment;
Office administration
|
Owned
|
Witten, Germany
|
Manufacturing, development and distribution of health care equipment;
Office administration
|
Owned
|
Navan, County Meath, Ireland
|
Office administration
|
Owned
|
Kawagawa, Japan
|
Office administration
|
Leased
|
Tijuana, Mexico
|
Manufacturing and distribution of health care equipment;
Office administration
|
Leased
|
Monterrey, Mexico
|
Manufacturing of health care equipment
|
Owned
|
Las Piedras, Puerto Rico
|
Manufacturing of surgical products
|
Owned
|
Singapore
|
Manufacturing and development of health care equipment;
Office administration
|
Leased
|
Lulea, Sweden
|
Manufacturing, development and distribution of health care equipment;
Office administration
|
Owned
|
Redditch, UK*
|
Manufacturing of surgical products;
Office administration
|
Leased
|
Item 5.
|
MAR
KET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
Years Ended September 30
|
||||||||||||||||||||||||
2015
|
2014
|
|||||||||||||||||||||||
Quarter Ended:
|
High
|
Low
|
Cash
Dividends
Declared
|
High
|
Low
|
Cash
Dividends
Declared
|
||||||||||||||||||
December 31
|
$ | 47.32 | $ | 39.58 | $ | 0.1525 | $ | 42.56 | $ | 35.64 | $ | 0.1375 | ||||||||||||
March 31
|
$ | 49.35 | $ | 44.69 | $ | 0.1600 | $ | 44.64 | $ | 34.94 | $ | 0.1525 | ||||||||||||
June 30
|
$ | 57.95 | $ | 48.16 | $ | 0.1600 | $ | 41.66 | $ | 35.45 | $ | 0.1525 | ||||||||||||
September 30
|
$ | 58.73 | $ | 49.30 | $ | 0.1600 | $ | 44.46 | $ | 38.85 | $ | 0.1525 |
Maximum
|
||||||||||||||||
Total Number
|
Approximate
|
|||||||||||||||
of Shares
|
Dollar Value
|
|||||||||||||||
Total
|
Purchased as
|
of Shares That
|
||||||||||||||
Number
|
Average
|
Part of Publicly
|
May Yet Be
|
|||||||||||||
of Shares
|
Price Paid
|
Announced Plans or
|
Purchased Under
|
|||||||||||||
Period
|
Purchased (1)
|
per Share
|
Programs (2)
|
the Programs (2)
|
||||||||||||
|
||||||||||||||||
July 1, 2015 - July 31, 2015
|
426 | $ | 54.21 | - | $ | 64.7 | ||||||||||
August 1, 2015 - August 31, 2015
|
728 | $ | 53.43 | - | $ | 64.7 | ||||||||||
September 1, 2015 - September 30, 2015
|
113,222 | $ | 51.91 | - | $ | 64.7 | ||||||||||
Total
|
114,376 | $ | 51.93 | - | $ | 64.7 |
(1)
|
Shares purchased during the quarter ended September 30, 2015 were in connection with employee payroll tax withholding for restricted and deferred stock distributions.
|
(2)
|
In September 2013, the Board approved an expansion of its previously announced share repurchase authorization to a total of $190.0 million. As of September 30, 2015, a cumulative total of $125.3 million has been used under this existing authorization. The plan does not have an expiration date and currently there are no plans to terminate this program in the future.
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
|
HRC
|
$100
|
$ 83
|
$ 82
|
$103
|
$121
|
$153
|
S & P 500
|
$100
|
$ 99
|
$126
|
$147
|
$172
|
$168
|
Peer Group
|
$100
|
$104
|
$135
|
$141
|
$166
|
$196
|
|
*
|
For purposes of the Stock Performance Graph above, our Peer Group is comprised of: Alere Inc.; CR Bard Inc.; Chemed Corp.; CONMED Corporation; DENTSPLY International Inc.; Edwards Lifesciences Corp.; Hologic Inc.; IDEXX Laboratories, Inc.; Integra Lifesciences Holdings Corporation; Intuitive Surgical, Inc.; Invacare Corporation; MEDNAX, Inc.; PerkinElmer Inc.; ResMed Inc.; Sirona Dental Systems Labs Inc.; Steris Corp.; Teleflex Incorporated.; The Cooper Companies Inc.; Varian Medical Systems, Inc.; and West Pharmaceutical Services, Inc.
|
2015
|
2014
|
2013
|
2012
|
2011
|
||||||||||||||||
Net revenue
|
$ | 1,988.2 | $ | 1,686.1 | $ | 1,716.2 | $ | 1,634.3 | $ | 1,591.7 | ||||||||||
Net income
|
$ | 46.8 | $ | 60.6 | $ | 105.0 | $ | 120.8 | $ | 133.5 | ||||||||||
Net income attributable to common shareholders
|
$ | 47.7 | $ | 60.6 | $ | 105.0 | $ | 120.8 | $ | 133.3 | ||||||||||
Net income attributable to common shareholders per share - Basic
|
$ | 0.83 | $ | 1.05 | $ | 1.75 | $ | 1.94 | $ | 2.11 | ||||||||||
Net income attributable to common shareholders per share - Diluted
|
$ | 0.82 | $ | 1.04 | $ | 1.74 | $ | 1.94 | $ | 2.09 | ||||||||||
Total assets
|
$ | 4,457.6 | $ | 1,751.3 | $ | 1,586.8 | $ | 1,627.6 | $ | 1,299.1 | ||||||||||
Long-term obligations
|
$ | 2,175.2 | $ | 364.1 | $ | 225.8 | $ | 237.5 | $ | 50.8 | ||||||||||
Cash flows from operating activities
|
$ | 213.8 | $ | 210.3 | $ | 263.2 | $ | 261.7 | $ | 222.5 | ||||||||||
Capital expenditures
|
$ | 121.3 | $ | 62.7 | $ | 65.3 | $ | 77.8 | $ | 68.9 | ||||||||||
Cash flows from investing activities
|
$ | (1,756.4 | ) | $ | (294.5 | ) | $ | (58.6 | ) | $ | (539.5 | ) | $ | (78.0 | ) | |||||
Cash flows from financing activities
|
$ | 1,642.7 | $ | 63.8 | $ | (161.5 | ) | $ | 135.6 | $ | (101.9 | ) | ||||||||
Cash dividends per share
|
$ | 0.6325 | $ | 0.5950 | $ | 0.5250 | $ | 0.4875 | $ | 0.4300 |
Item 7.
|
MANAGEMENT'S
DISC
USSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Years Ended September 30
|
||||||||||||||||||||||||
|
% of Related
|
|
% of Related
|
|
% of Related
|
|||||||||||||||||||
(Dollars in millions except per share data)
|
2015
|
Revenue
|
2014
|
Revenue
|
2013
|
Revenue
|
||||||||||||||||||
Net Revenue
|
||||||||||||||||||||||||
Capital sales
|
$ | 1,604.5 | 80.7 | % | $ | 1,301.4 | 77.2 | % | $ | 1,308.3 | 76.2 | % | ||||||||||||
Rental revenue
|
383.7 | 19.3 | % | 384.7 | 22.8 | % | 407.9 | 23.8 | % | |||||||||||||||
Total Revenue
|
1,988.2 | 100.0 | % | 1,686.1 | 100.0 | % | 1,716.2 | 100.0 | % | |||||||||||||||
Gross Profit
|
||||||||||||||||||||||||
Capital sales
|
683.3 | 42.6 | % | 571.2 | 43.9 | % | 560.5 | 42.8 | % | |||||||||||||||
Rental revenue
|
197.0 | 51.3 | % | 208.7 | 54.3 | % | 219.8 | 53.9 | % | |||||||||||||||
Total Gross Profit
|
880.3 | 44.3 | % | 779.9 | 46.3 | % | 780.3 | 45.5 | % | |||||||||||||||
Research and development expenses
|
91.8 | 4.6 | % | 71.9 | 4.3 | % | 70.2 | 4.1 | % | |||||||||||||||
Selling and administrative expenses
|
664.2 | 33.4 | % | 548.3 | 32.5 | % | 549.5 | 32.0 | % | |||||||||||||||
Special charges
|
41.2 | 2.1 | % | 37.1 | 2.2 | % | 5.7 | 0.3 | % | |||||||||||||||
Operating Profit
|
83.1 | 4.2 | % | 122.6 | 7.3 | % | 154.9 | 9.0 | % | |||||||||||||||
Other income (expense), net
|
(18.0 | ) | -0.9 | % | (7.4 | ) | -0.4 | % | (10.9 | ) | -0.6 | % | ||||||||||||
Income Before Income Taxes
|
65.1 | 3.3 | % | 115.2 | 6.8 | % | 144.0 | 8.4 | % | |||||||||||||||
Income tax expense
|
18.3 | 0.9 | % | 54.6 | 3.2 | % | 39.0 | 2.3 | % | |||||||||||||||
Net Income
|
46.8 | 2.4 | % | 60.6 | 3.6 | % | 105.0 | 6.1 | % | |||||||||||||||
Less: Net income attributable to noncontrolling interest
|
(0.9 | ) | - | - | - | - | - | |||||||||||||||||
Net Income Attributable to Common Shareholders
|
$ | 47.7 | 2.4 | % | $ | 60.6 | 3.6 | % | $ | 105.0 | 6.1 | % | ||||||||||||
Net Income Attributable to Common Shareholders
|
||||||||||||||||||||||||
per Common Share - Diluted
|
$ | 0.82 | $ | 1.04 | $ | 1.74 |
Note: Certain percentage amounts may not add due to rounding.
|
Years Ended September 30
|
Percentage Change
|
|||||||||||||||
|
|
Constant
|
||||||||||||||
(Dollars in millions)
|
2015
|
2014
|
As Reported
|
Currency
|
||||||||||||
Revenue:
|
||||||||||||||||
Capital sales
|
$ | 1,604.5 | $ | 1,301.4 | 23.3 | 29.9 | ||||||||||
Rental revenue
|
383.7 | 384.7 | (0.3 | ) | 1.7 | |||||||||||
Total Revenue
|
$ | 1,988.2 | $ | 1,686.1 | 17.9 | 23.5 |
Years Ended September 30
|
||||||||||||
Percentage
|
||||||||||||
(Dollars in millions)
|
2015
|
2014
|
Change
|
|||||||||
Gross Profit
|
||||||||||||
Capital sales
|
$ | 683.3 | $ | 571.2 | 19.6 | |||||||
Percent of Related Revenue
|
42.6 | % | 43.9 | % | ||||||||
Rental revenue
|
$ | 197.0 | $ | 208.7 | (5.6 | ) | ||||||
Percent of Related Revenue
|
51.3 | % | 54.3 | % | ||||||||
Total Gross Profit
|
$ | 880.3 | $ | 779.9 | 12.9 | |||||||
Percent of Related Revenue
|
44.3 | % | 46.3 | % |
Years Ended September 30
|
||||||||||||
|
|
Percentage
|
||||||||||
(Dollars in millions)
|
2015
|
2014
|
Change
|
|||||||||
Research and development expenses
|
$ | 91.8 | $ | 71.9 | 27.7 | |||||||
Percent of Total Revenue
|
4.6 | % | 4.3 | % | ||||||||
Selling and administrative expenses
|
$ | 664.2 | $ | 548.3 | 21.1 | |||||||
Percent of Total Revenue
|
33.4 | % | 32.5 | % | ||||||||
Special charges
|
$ | 41.2 | $ | 37.1 | 11.1 | |||||||
Interest expense
|
$ | (18.4 | ) | $ | (9.8 | ) | 87.8 | |||||
Investment income and other, net
|
$ | 0.4 | $ | 2.4 | (83.3 | ) |
Years Ended September 30
|
||||||||||||||||||||||||||||
2015
|
2014
|
|||||||||||||||||||||||||||
(Dollars in millions, except for per share amounts)
|
Income Before
Income Taxes
|
Income Tax
Expense
|
NCI
|
Diluted EPS
|
Income Before
Income Taxes
|
Income Tax
Expense
|
Diluted EPS
1
|
|||||||||||||||||||||
GAAP Earnings
|
$ | 65.1 | $ | 18.3 | $ | (0.9 | ) | $ | 0.82 | $ | 115.2 | $ | 54.6 | $ | 1.04 | |||||||||||||
Adjustments:
|
||||||||||||||||||||||||||||
Acquisition and integration costs
|
62.8 | 18.0 | - | 0.76 | 16.3 | 5.0 | 0.19 | |||||||||||||||||||||
Acquisition-related intangible asset amortization
|
34.1 | 9.8 | - | 0.42 | 28.8 | 8.7 | 0.34 | |||||||||||||||||||||
Employee benefits change
|
- | - | - | - | (13.4 | ) | (5.1 | ) | (0.14 | ) | ||||||||||||||||||
FDA remediation expenses
|
3.8 | 1.2 | - | 0.04 | 4.5 | 1.7 | 0.05 | |||||||||||||||||||||
Field corrective actions
|
4.5 | 1.4 | - | 0.05 | (1.7 | ) | (0.6 | ) | (0.02 | ) | ||||||||||||||||||
Litigation settlements and expenses
|
(0.6 | ) | (0.2 | ) | - | (0.01 | ) | - | - | - | ||||||||||||||||||
Special charges
|
41.2 | 10.7 | - | 0.52 | 37.1 | 10.9 | 0.45 | |||||||||||||||||||||
Supplemental stock compensation charge
|
6.1 | 2.2 | - | 0.07 | - | - | - | |||||||||||||||||||||
Foreign valuation allowance and acquisition dividend tax
|
- | 1.9 | - | (0.03 | ) | - | (20.3 | ) | 0.35 | |||||||||||||||||||
Adjusted Earnings
|
$ | 217.0 | $ | 63.3 | $ | (0.9 | ) | $ | 2.64 | $ | 186.8 | $ | 54.9 | $ | 2.25 |
1
Total does not add due to rounding
|
||||||||||||||||||||||||||||
NCI = Net loss attributable to noncontrolling interests
|
Years Ended September 30
|
Percentage Change
|
|||||||||||||||
|
|
Constant
|
||||||||||||||
(Dollars in millions)
|
2015
|
2014
|
As Reported
|
Currency
|
||||||||||||
Revenue:
|
||||||||||||||||
North America
|
$ | 1,002.0 | $ | 888.9 | 12.7 | 13.4 | ||||||||||
Surgical and Respiratory Care
|
506.6 | 301.6 | 68.0 | 78.3 | ||||||||||||
International
|
429.4 | 495.6 | (13.4 | ) | (2.1 | ) | ||||||||||
Welch Allyn
1
|
50.2 | - | N/M | N/M | ||||||||||||
Total revenue
|
$ | 1,988.2 | $ | 1,686.1 | 17.9 | 23.5 | ||||||||||
Divisional income:
|
||||||||||||||||
North America
|
$ | 204.1 | $ | 165.0 | 23.7 | |||||||||||
Surgical and Respiratory Care
|
80.5 | 68.6 | 17.3 | |||||||||||||
International
|
12.8 | 24.9 | (48.6 | ) |
Years Ended September 30
|
Percentage Change
|
|||||||||||||||
|
|
Constant
|
||||||||||||||
(Dollars in millions)
|
2014
|
2013
|
As Reported
|
Currency
|
||||||||||||
Revenue:
|
||||||||||||||||
Capital sales
|
$ | 1,301.4 | $ | 1,308.3 | (0.5 | ) | (1.1 | ) | ||||||||
Rental revenue
|
384.7 | 407.9 | (5.7 | ) | (6.0 | ) | ||||||||||
Total Revenue
|
$ | 1,686.1 | $ | 1,716.2 | (1.8 | ) | (2.2 | ) |
Years Ended September 30
|
||||||||||||
Percentage
|
||||||||||||
(Dollars in millions)
|
2014
|
2013
|
Change
|
|||||||||
Gross Profit
|
||||||||||||
Capital sales
|
$ | 571.2 | $ | 560.5 | 1.9 | |||||||
Percent of Related Revenue
|
43.9 | % | 42.8 | % | ||||||||
Rental revenue
|
$ | 208.7 | $ | 219.8 | (5.1 | ) | ||||||
Percent of Related Revenue
|
54.3 | % | 53.9 | % | ||||||||
Total Gross Profit
|
$ | 779.9 | $ | 780.3 | (0.1 | ) | ||||||
Percent of Related Revenue
|
46.3 | % | 45.5 | % |
Years Ended September 30
|
||||||||||||
|
|
Percentage
|
||||||||||
(Dollars in millions)
|
2014
|
2013
|
Change
|
|||||||||
Research and development expenses
|
$ | 71.9 | $ | 70.2 | 2.4 | |||||||
Percent of Total Revenue
|
4.3 | % | 4.1 | % | ||||||||
Selling and administrative expenses
|
$ | 548.3 | $ | 549.5 | (0.2 | ) | ||||||
Percent of Total Revenue
|
32.5 | % | 32.0 | % | ||||||||
Special charges
|
$ | 37.1 | $ | 5.7 | 550.9 | |||||||
Interest expense
|
$ | (9.8 | ) | $ | (9.5 | ) | 3.2 | |||||
Investment income and other, net
|
$ | 2.4 | $ | (1.4 | ) | (27.4 | ) |
Years Ended September 30
|
||||||||||||||||||||||||
2014
|
2013
|
|||||||||||||||||||||||
(Dollars in millions, except for per share amounts)
|
Income Before
Income Taxes
|
Income Tax
Expense
|
Diluted EPS
1
|
Income Before
Income Taxes
|
Income Tax
Expense
|
Diluted EPS
|
||||||||||||||||||
GAAP Earnings
|
$ | 115.2 | $ | 54.6 | $ | 1.04 | $ | 144.0 | $ | 39.0 | $ | 1.74 | ||||||||||||
Adjustments:
|
||||||||||||||||||||||||
Acquisition and integration costs
|
16.3 | 5.0 | 0.19 | 8.8 | 2.9 | 0.10 | ||||||||||||||||||
Acquisition-related intangible asset amortization
|
28.8 | 8.7 | 0.34 | 27.7 | 10.1 | 0.29 | ||||||||||||||||||
Field corrective actions
|
(1.7 | ) | (0.6 | ) | (0.02 | ) | 12.2 | 4.0 | 0.14 | |||||||||||||||
Employee benefits change
|
(13.4 | ) | (5.1 | ) | (0.14 | ) | - | - | - | |||||||||||||||
FDA remediation expenses
|
4.5 | 1.7 | 0.05 | 6.1 | 2.3 | 0.06 | ||||||||||||||||||
Litigation charge
|
- | - | - | 0.5 | 0.5 | - | ||||||||||||||||||
Special charges
|
37.1 | 10.9 | 0.45 | 5.7 | 1.8 | 0.06 | ||||||||||||||||||
Foreign valuation allowance and acquisition dividend tax
|
- | (20.3 | ) | 0.35 | - | - | - | |||||||||||||||||
International tax reorganization
|
- | - | - | - | 0.8 | (0.01 | ) | |||||||||||||||||
Adjusted Earnings
|
$ | 186.8 | $ | 54.9 | $ | 2.25 | $ | 205.0 | $ | 61.4 | $ | 2.38 |
Years Ended September 30
|
Percentage Change
|
|||||||||||||||
|
|
Constant
|
||||||||||||||
(Dollars in millions)
|
2014
|
2013
|
As Reported
|
Currency
|
||||||||||||
Revenue:
|
||||||||||||||||
North America
|
$ | 888.9 | $ | 958.3 | (7.2 | ) | (6.9 | ) | ||||||||
Surgical and Respiratory Care
|
301.6 | 245.8 | 22.7 | 22.0 | ||||||||||||
International
|
495.6 | 512.1 | (3.2 | ) | (5.1 | ) | ||||||||||
Total revenue
|
$ | 1,686.1 | $ | 1,716.2 | (1.8 | ) | (2.2 | ) | ||||||||
Divisional income:
|
||||||||||||||||
North America
|
$ | 165.0 | $ | 201.7 | (18.2 | ) | ||||||||||
Surgical and Respiratory Care
|
68.6 | 56.8 | 20.8 | |||||||||||||
International
|
24.9 | 33.5 | (25.7 | ) |
Years Ended September 30
|
||||||||||||
(Dollars in millions)
|
2015
|
2014
|
2013
|
|||||||||
Cash Flows Provided By (Used In):
|
||||||||||||
Operating activities
|
$ | 213.8 | $ | 210.3 | $ | 263.2 | ||||||
Investing activities
|
(1,756.4 | ) | (294.5 | ) | (58.6 | ) | ||||||
Financing activities
|
1,642.7 | 63.8 | (161.5 | ) | ||||||||
Effect of exchange rate changes on cash
|
(6.6 | ) | (7.7 | ) | - | |||||||
Increase (Decrease) in Cash and Cash Equivalents
|
$ | 93.5 | $ | (28.1 | ) | $ | 43.1 |
|
·
|
$1.0 billion senior secured Term Loan A facility (“TLA Facility”), maturing in September 2020
|
|
·
|
$800.0 million senior secured Term Loan B facility (“TLB Facility”), maturing in September 2022
|
|
·
|
Senior secured revolving credit facility (“Revolving Credit Facility”), providing borrowing capacity of up to $500.0 million, maturing in September 2020
|
|
·
|
$425.0 million of senior unsecured notes (“Senior Notes”), maturing in September 2023
|
Fiscal Quarter Ended
|
Maximum
Secured Net
Leverage Ratio
|
Minimum
Interest Coverage
Ratio
|
December 31, 2015
|
4.75x
|
3.25x
|
December 31, 2016
|
4.50x
|
3.25x
|
December 31, 2017
|
4.00x
|
3.50x
|
December 31, 2018
|
3.50x
|
3.75x
|
December 31, 2019 and thereafter
|
3.00x
|
4.00x
|
Payments Due by Period
|
||||||||||||||||||||
Less Than
|
1 - 3 | 3 - 5 |
After 5
|
|||||||||||||||||
(Dollars in millions)
|
Total
|
1 Year
|
Years
|
Years
|
Years
|
|||||||||||||||
Contractual Obligations
|
||||||||||||||||||||
Long-term debt obligations
|
$ | 2,272.3 | $ | 58.0 | $ | 194.3 | $ | 791.2 | $ | 1,228.8 | ||||||||||
Interest payments relating to long-term debt (1)
|
561.3 | 78.7 | 166.2 | 164.0 | 152.4 | |||||||||||||||
Operating lease obligations
|
73.8 | 28.2 | 30.5 | 9.5 | 5.6 | |||||||||||||||
Pension and postretirement
|
||||||||||||||||||||
health care benefit funding (2)
|
31.7 | 2.9 | 6.0 | 6.3 | 16.5 | |||||||||||||||
Purchase obligations (3)
|
174.8 | 132.0 | 31.3 | 11.2 | 0.3 | |||||||||||||||
Other long-term liabilities (4)
|
38.5 | - | 15.4 | 15.2 | 7.9 | |||||||||||||||
Total contractual cash obligations
|
$ | 3,152.4 | $ | 299.8 | $ | 443.7 | $ | 997.4 | $ | 1,411.5 |
(1)
|
Interest payments on our long-term debt are projected based on the contractual rates of remaining debt securities.
|
(2)
|
Based on our funded status as of September 30, 2015, we currently do not anticipate any further contributions to our master pension plan in fiscal 2016.
|
(3)
|
Purchase obligations represent contractual obligations under various take-or-pay arrangements executed in the normal course of business. These commitments represent future purchases in line with expected usage to obtain favorable pricing. Also included are obligations arising from purchase orders for which we have made firm commitments. As a result, we believe that the purchase obligations portion of our contractual obligations is substantially those obligations for which we are certain to pay, regardless of future facts and circumstances. We expect to fund purchase obligations with operating cash flows and current cash balances.
|
(4)
|
Other long-term liabilities include deferred compensation arrangements, self-insurance reserves, and other various liabilities.
|
•
|
Evidence of an arrangement:
An agreement with the customer reflecting the terms and conditions to deliver products or services serves as evidence of an arrangement.
|
•
|
Delivery:
For products, delivery is considered to occur upon receipt by the customer and the transfer of title and risk of loss. For rental services, delivery is considered to occur when the services are rendered.
|
•
|
Fixed or determinable price
: The sales price is considered fixed or determinable if it is not subject to refund or adjustment.
|
•
|
Collection is deemed probable
: At or prior to the time of a transaction, credit reviews of each customer are performed to determine the creditworthiness of the customer. Collection is deemed probable if the customer is expected to be able to pay amounts under the arrangement as those amounts become due. If collection is not probable, revenue is recognized when collection becomes probable, generally upon cash collection.
|
|
Page
|
Financial Statements:
|
|
42
|
|
43
|
|
44
|
|
45
|
|
46
|
|
47
|
|
48
|
|
49
|
|
Financial Statement Schedule for the fiscal years ended September 30, 2015, 2014 and 2013:
|
|
83
|
|
All other schedules are omitted because they are not applicable or the required information is shown in the financial statements or the notes thereto.
|
|
1)
|
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
|
|
2)
|
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of our Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States and that our receipts and expenditures are being made only in accordance with authorizations of our management and our Board of Directors; and
|
|
3)
|
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our Consolidated Financial Statements.
|
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Net Revenue
|
||||||||||||
Capital sales
|
$ | 1,604.5 | $ | 1,301.4 | $ | 1,308.3 | ||||||
Rental revenue
|
383.7 | 384.7 | 407.9 | |||||||||
Total revenue
|
1,988.2 | 1,686.1 | 1,716.2 | |||||||||
Cost of Revenue
|
||||||||||||
Cost of goods sold
|
921.2 | 730.2 | 747.8 | |||||||||
Rental expenses
|
186.7 | 176.0 | 188.1 | |||||||||
Total cost of revenue
|
1,107.9 | 906.2 | 935.9 | |||||||||
Gross Profit
|
880.3 | 779.9 | 780.3 | |||||||||
Research and development expenses
|
91.8 | 71.9 | 70.2 | |||||||||
Selling and administrative expenses
|
664.2 | 548.3 | 549.5 | |||||||||
Special charges (Note 8)
|
41.2 | 37.1 | 5.7 | |||||||||
Operating Profit
|
83.1 | 122.6 | 154.9 | |||||||||
Interest expense
|
(18.4 | ) | (9.8 | ) | (9.5 | ) | ||||||
Investment income and other, net
|
0.4 | 2.4 | (1.4 | ) | ||||||||
Income Before Income Taxes
|
65.1 | 115.2 | 144.0 | |||||||||
Income tax expense (Note 9)
|
18.3 | 54.6 | 39.0 | |||||||||
Net Income
|
46.8 | 60.6 | 105.0 | |||||||||
Less: Net loss attributable to noncontrolling interests
|
(0.9 | ) | - | - | ||||||||
Net Income Attributable to Common Shareholders
|
$ | 47.7 | $ | 60.6 | $ | 105.0 | ||||||
Net Income Attributable to Common Shareholders
|
||||||||||||
per Common Share - Basic
|
$ | 0.83 | $ | 1.05 | $ | 1.75 | ||||||
Net Income Attributable to Common Shareholders
|
||||||||||||
per Common Share - Diluted
|
$ | 0.82 | $ | 1.04 | $ | 1.74 | ||||||
Dividends per Common Share
|
$ | 0.6325 | $ | 0.5950 | $ | 0.5250 | ||||||
Average Common Shares Outstanding - Basic (thousands) (Note 10)
|
57,249 | 57,555 | 59,910 | |||||||||
Average Common Shares Outstanding - Diluted (thousands) (Note 10)
|
58,536 | 58,523 | 60,250 |
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Net Income
|
$ | 46.8 | $ | 60.6 | $ | 105.0 | ||||||
Other Comprehensive Income (Loss), Net of Tax:
|
||||||||||||
Available-for-sale securities and currency hedges
|
- | 0.3 | 0.1 | |||||||||
Foreign currency translation adjustment
|
(58.6 | ) | (29.6 | ) | 12.6 | |||||||
Change in pension and postretirement defined benefit plans
|
(8.1 | ) | (9.1 | ) | 29.6 | |||||||
Total Other Comprehensive Income (Loss), Net of Tax
|
(66.7 | ) | (38.4 | ) | 42.3 | |||||||
Total Comprehensive Income (Loss)
|
(19.9 | ) | 22.2 | 147.3 | ||||||||
Less: Comprehensive loss attributable to noncontrolling interests
|
(0.9 | ) | - | - | ||||||||
Total Comprehensive Income (Loss) Attributable to Common Shareholders
|
$ | (19.0 | ) | $ | 22.2 | $ | 147.3 |
September 30
|
||||||||
2015
|
2014
|
|||||||
ASSETS
|
||||||||
Current Assets
|
||||||||
Cash and cash equivalents
|
$ | 192.8 | $ | 99.3 | ||||
Trade accounts receivable, less allowances of $26.0 in 2015 and $31.4 in 2014 (Note 1)
|
494.7 | 411.0 | ||||||
Inventories (Note 1)
|
267.4 | 176.2 | ||||||
Deferred income taxes (Notes 1 and 9)
|
77.0 | 40.9 | ||||||
Other current assets
|
109.1 | 51.9 | ||||||
Total current assets
|
1,141.0 | 779.3 | ||||||
Property, plant, and equipment (Note 1)
|
976.4 | 849.6 | ||||||
Less accumulated depreciation
|
(598.0 | ) | (588.1 | ) | ||||
Property, plant, and equipment, net
|
378.4 | 261.5 | ||||||
Intangible assets:
|
||||||||
Goodwill (Notes 1, 2 and 3)
|
1,610.5 | 399.8 | ||||||
Software and other, net (Notes 1 and 2)
|
1,247.7 | 261.1 | ||||||
Deferred income taxes (Notes 1 and 9)
|
21.6 | 23.0 | ||||||
Other assets
|
58.4 | 26.6 | ||||||
Total Assets
|
$ | 4,457.6 | $ | 1,751.3 | ||||
LIABILITIES
|
||||||||
Current Liabilities
|
||||||||
Trade accounts payable
|
$ | 136.3 | $ | 112.7 | ||||
Short-term borrowings (Note 4)
|
58.0 | 126.9 | ||||||
Accrued compensation
|
171.8 | 89.2 | ||||||
Accrued product warranties (Note 1)
|
32.1 | 28.4 | ||||||
Accrued rebates
|
33.7 | 7.1 | ||||||
Other current liabilities
|
146.9 | 78.0 | ||||||
Total current liabilities
|
578.8 | 442.3 | ||||||
Long-term debt (Note 4)
|
2,175.2 | 364.1 | ||||||
Accrued pension and postretirement benefits (Note 6)
|
118.8 | 76.9 | ||||||
Deferred income taxes (Notes 1 and 9)
|
380.6 | 31.0 | ||||||
Other long-term liabilities
|
47.3 | 30.5 | ||||||
Total Liabilities
|
3,300.7 | 944.8 | ||||||
Commitments and Contingencies (Note 13)
|
||||||||
SHAREHOLDERS' EQUITY (Note 7)
|
||||||||
Capital Stock:
|
||||||||
Preferred stock - without par value:
|
||||||||
Authorized - 1,000,000 shares; none issued or outstanding
|
- | - | ||||||
Common stock - without par value:
|
||||||||
Authorized - 199,000,000
|
||||||||
Issued - 88,457,634 shares in 2015 and 80,323,912 shares in 2014
|
4.4 | 4.4 | ||||||
Additional paid-in-capital
|
562.0 | 134.1 | ||||||
Retained earnings
|
1,509.9 | 1,499.8 | ||||||
Accumulated other comprehensive loss (Note 1)
|
(140.8 | ) | (74.1 | ) | ||||
Treasury stock, common shares at cost: 2015 - 23,291,738 and 2014 - 22,884,001
|
(788.6 | ) | (757.7 | ) | ||||
Total Shareholders' Equity Attributable to Common Shareholders
|
1,146.9 | 806.5 | ||||||
Noncontrolling interests
|
10.0 | - | ||||||
Total Shareholders' Equity
|
1,156.9 | 806.5 | ||||||
Total Liabilities and Shareholders' Equity
|
$ | 4,457.6 | $ | 1,751.3 |
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Operating Activities
|
||||||||||||
Net income
|
$ | 46.8 | $ | 60.6 | $ | 105.0 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||||||
Depreciation
|
73.6 | 65.4 | 71.2 | |||||||||
Amortization
|
10.5 | 12.2 | 17.9 | |||||||||
Acquisition-related intangible asset amortization
|
34.1 | 28.8 | 27.7 | |||||||||
Provision for deferred income taxes
|
(22.3 | ) | 3.9 | (14.8 | ) | |||||||
Loss on disposal of property, equipment leased to others,
|
||||||||||||
intangible assets and impairments
|
0.5 | 7.2 | 1.5 | |||||||||
Pension settlement charge
|
9.6 | - | - | |||||||||
Stock compensation
|
25.0 | 18.0 | 13.5 | |||||||||
Excess tax benefits from employee stock plans
|
(3.6 | ) | 0.3 | (0.3 | ) | |||||||
Change in working capital excluding cash, current debt,
|
||||||||||||
acquisitions and dispositions:
|
||||||||||||
Trade accounts receivable
|
(39.7 | ) | 17.1 | 30.8 | ||||||||
Inventories
|
11.0 | 9.1 | 8.4 | |||||||||
Other current assets
|
(7.7 | ) | (2.6 | ) | (6.5 | ) | ||||||
Trade accounts payable
|
0.7 | 7.0 | 0.1 | |||||||||
Accrued expenses and other liabilities
|
53.8 | (12.5 | ) | (0.2 | ) | |||||||
Other, net
|
21.5 | (4.2 | ) | 8.9 | ||||||||
Net cash provided by operating activities
|
213.8 | 210.3 | 263.2 | |||||||||
Investing Activities
|
||||||||||||
Capital expenditures and purchases of intangible assets
|
(121.3 | ) | (62.7 | ) | (65.3 | ) | ||||||
Proceeds on sale of property and equipment leased to others
|
1.5 | 2.4 | 5.9 | |||||||||
Payment for acquisition of businesses, net of cash acquired
|
(1,638.7 | ) | (239.5 | ) | - | |||||||
Refund on acquisition of businesses
|
- | 4.6 | 0.8 | |||||||||
Other
|
2.1 | 0.7 | - | |||||||||
Net cash used in investing activities
|
(1,756.4 | ) | (294.5 | ) | (58.6 | ) | ||||||
Financing Activities
|
||||||||||||
Net change in short-term debt
|
(0.7 | ) | (0.2 | ) | - | |||||||
Borrowings on revolving credit facility
|
95.0 | 252.0 | - | |||||||||
Payments on revolving credit facility
|
(135.0 | ) | (57.0 | ) | (35.0 | ) | ||||||
Proceeds from long-term debt
|
2,225.0 | 0.8 | - | |||||||||
Payment of long-term debt
|
(401.6 | ) | (11.4 | ) | (10.1 | ) | ||||||
Payment of acquired debt
|
- | (26.8 | ) | - | ||||||||
Repurchase of registered debentures
|
(5.9 | ) | - | - | ||||||||
Debt issuance costs
|
(50.3 | ) | - | - | ||||||||
Purchase of noncontrolling interest of former joint venture
|
(1.9 | ) | (1.3 | ) | (1.6 | ) | ||||||
Payment of cash dividends
|
(37.1 | ) | (34.2 | ) | (31.2 | ) | ||||||
Proceeds from exercise of stock options
|
12.1 | 11.5 | 7.6 | |||||||||
Proceeds from stock issuance
|
2.8 | 2.5 | 2.5 | |||||||||
Excess tax benefits from employee stock plans
|
3.6 | (0.3 | ) | 0.3 | ||||||||
Treasury stock acquired
|
(63.3 | ) | (71.8 | ) | (94.0 | ) | ||||||
Net cash provided by (used in) financing activities
|
1,642.7 | 63.8 | (161.5 | ) | ||||||||
Effect of exchange rate changes on cash
|
(6.6 | ) | (7.7 | ) | - | |||||||
Net Cash Flows
|
93.5 | (28.1 | ) | 43.1 | ||||||||
Cash and Cash Equivalents
|
||||||||||||
At beginning of period
|
99.3 | 127.4 | 84.3 | |||||||||
At end of period
|
$ | 192.8 | $ | 99.3 | $ | 127.4 | ||||||
Supplemental cash flow information:
|
||||||||||||
Cash paid for income taxes
|
$ | 49.1 | $ | 44.4 | $ | 68.1 | ||||||
Cash paid for interest
|
$ | 6.3 | $ | 7.8 | $ | 7.5 | ||||||
Non-cash investing and financing activities:
|
||||||||||||
Treasury stock issued under stock compensation plans
|
$ | 32.4 | $ | 20.6 | $ | 18.4 | ||||||
Common stock issued for acquisition of businesses
|
$ | 416.3 | $ | - | $ | - |
Accumulated
|
Total Equity
|
|||||||||||||||||||||||||||||||||||||||
Common Stock
|
Other
|
Common Stock
|
Attributable to
|
|||||||||||||||||||||||||||||||||||||
Shares
|
Additional
|
Retained
|
Comprehensive
|
in Treasury
|
Common
|
Noncontrolling
|
||||||||||||||||||||||||||||||||||
Outstanding
|
Amount
|
Paid-in-Capital
|
Earnings
|
Income (Loss)
|
Shares
|
Amount
|
Shareholders
|
Interests
|
Total
|
|||||||||||||||||||||||||||||||
Balance at September 30, 2012
|
60,796,923 | $ | 4.4 | $ | 116.8 | $ | 1,400.3 | $ | (78.0 | ) | 19,526,989 | $ | (630.9 | ) | $ | 812.6 | $ | - | $ | 812.6 | ||||||||||||||||||||
Net income
|
- | - | - | 105.0 | - | - | - | 105.0 | - | 105.0 | ||||||||||||||||||||||||||||||
Other comprehensive income, net of tax of ($18.1)
|
- | - | - | - | 42.3 | - | - | 42.3 | - | 42.3 | ||||||||||||||||||||||||||||||
Dividends
|
- | - | 0.3 | (31.5 | ) | - | - | - | (31.2 | ) | - | (31.2 | ) | |||||||||||||||||||||||||||
Treasury shares acquired
|
(2,844,765 | ) | - | - | - | - | 2,844,765 | (94.0 | ) | (94.0 | ) | - | (94.0 | ) | ||||||||||||||||||||||||||
Stock awards and option exercises
|
571,234 | - | 5.6 | - | - | (571,234 | ) | 18.4 | 24.0 | - | 24.0 | |||||||||||||||||||||||||||||
Balance at September 30, 2013
|
58,523,392 | 4.4 | 122.7 | 1,473.8 | (35.7 | ) | 21,800,520 | (706.5 | ) | 858.7 | 858.7 | |||||||||||||||||||||||||||||
Net income
|
- | - | - | 60.6 | - | - | - | 60.6 | - | 60.6 | ||||||||||||||||||||||||||||||
Other comprehensive loss, net of tax of $4.9
|
- | - | - | - | (38.4 | ) | - | - | (38.4 | ) | - | (38.4 | ) | |||||||||||||||||||||||||||
Dividends
|
- | - | 0.4 | (34.6 | ) | - | - | - | (34.2 | ) | - | (34.2 | ) | |||||||||||||||||||||||||||
Treasury shares acquired
|
(1,709,523 | ) | - | - | - | - | 1,709,523 | (71.8 | ) | (71.8 | ) | - | (71.8 | ) | ||||||||||||||||||||||||||
Stock awards and option exercises
|
626,042 | - | 11.0 | - | - | (626,042 | ) | 20.6 | 31.6 | - | 31.6 | |||||||||||||||||||||||||||||
Balance at September 30, 2014
|
57,439,911 | 4.4 | 134.1 | 1,499.8 | (74.1 | ) | 22,884,001 | (757.7 | ) | 806.5 | 806.5 | |||||||||||||||||||||||||||||
Net income
|
- | - | - | 47.7 | - | - | - | 47.7 | (0.9 | ) | 46.8 | |||||||||||||||||||||||||||||
Consolidation of noncontrolling interest
|
- | - | - | - | - | - | - | - | 10.9 | 10.9 | ||||||||||||||||||||||||||||||
Other comprehensive loss, net of tax of $5.1
|
- | - | - | - | (66.7 | ) | - | - | (66.7 | ) | - | (66.7 | ) | |||||||||||||||||||||||||||
Dividends
|
- | - | 0.5 | (37.6 | ) | - | - | - | (37.1 | ) | - | (37.1 | ) | |||||||||||||||||||||||||||
Issuance of common stock
|
8,133,722 | - | 416.3 | - | - | - | - | 416.3 | - | 416.3 | ||||||||||||||||||||||||||||||
Treasury shares acquired
|
(1,373,321 | ) | - | - | - | - | 1,373,321 | (63.3 | ) | (63.3 | ) | - | (63.3 | ) | ||||||||||||||||||||||||||
Stock awards and option exercises
|
965,584 | - | 11.1 | - | - | (965,584 | ) | 32.4 | 43.5 | - | 43.5 | |||||||||||||||||||||||||||||
Balance at September 30, 2015
|
65,165,896 | $ | 4.4 | $ | 562.0 | $ | 1,509.9 | $ | (140.8 | ) | 23,291,738 | $ | (788.6 | ) | $ | 1,146.9 | $ | 10.0 | $ | 1,156.9 |
September 30
|
||||||||
2015
|
2014
|
|||||||
Finished products
|
$ | 133.2 | $ | 93.5 | ||||
Work in process
|
46.1 | 17.3 | ||||||
Raw materials
|
88.1 | 65.4 | ||||||
Total
|
$ | 267.4 | $ | 176.2 |
Useful Life
|
||
Land improvements
|
6 - 15 years
|
|
Buildings and building equipment
|
10 - 40 years
|
|
Machinery and equipment
|
3 - 10 years
|
|
Equipment leased to others
|
2 -10 years
|
September 30
|
||||||||||||||||
2015
|
2014
|
|||||||||||||||
Accumulated
|
Accumulated
|
|||||||||||||||
Cost
|
Depreciation
|
Cost
|
Depreciation
|
|||||||||||||
Land and land improvements
|
$ | 23.3 | $ | 2.8 | $ | 19.4 | $ | 2.3 | ||||||||
Buildings and building equipment
|
196.2 | 90.3 | 158.3 | 88.6 | ||||||||||||
Machinery and equipment
|
369.5 | 226.5 | 321.3 | 213.7 | ||||||||||||
Equipment leased to others
|
387.4 | 278.4 | 350.6 | 283.5 | ||||||||||||
Total
|
$ | 976.4 | $ | 598.0 | $ | 849.6 | $ | 588.1 |
September 30
|
||||||||||||||||
2015
|
2014
|
|||||||||||||||
Amortization
|
Amortization
|
|||||||||||||||
Cost
|
and Impairment
|
Cost
|
and Impairment
|
|||||||||||||
Goodwill
|
$ | 2,083.3 | $ | 472.8 | $ | 872.6 | $ | 472.8 | ||||||||
Software
|
181.7 | 139.2 | 170.5 | 146.6 | ||||||||||||
Patents and Trademarks
|
497.6 | 16.9 | 67.1 | 16.0 | ||||||||||||
Other
|
872.8 | 148.3 | 306.8 | 120.7 | ||||||||||||
Total
|
$ | 3,635.4 | $ | 777.2 | $ | 1,417.0 | $ | 756.1 |
Amount
|
||||
2016
|
$ | 92.9 | ||
2017
|
$ | 85.8 | ||
2018
|
$ | 81.6 | ||
2019
|
$ | 78.0 | ||
2020
|
$ | 74.4 | ||
2021 and beyond
|
$ | 368.1 |
·
|
Level 1: Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.
|
·
|
Level 2: Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
|
·
|
Level 3: Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). Unobservable inputs shall be developed based on the best information available in the circumstances, which might include our own data.
|
2015
|
2014
|
2013
|
||||||||||
Balance at October 1
|
$ | 28.4 | $ | 38.1 | $ | 42.2 | ||||||
Provision for warranties during the period
|
14.7 | 9.8 | 29.2 | |||||||||
Warranty reserves acquired
|
7.1 | 3.0 | (2.6 | ) | ||||||||
Warranty claims incurred during the period
|
(18.1 | ) | (22.5 | ) | (30.7 | ) | ||||||
Balance at September 30
|
$ | 32.1 | $ | 28.4 | $ | 38.1 |
|
•
|
Evidence of an arrangement:
An agreement with the customer reflecting the terms and conditions to deliver products or services serves as evidence of an arrangement.
|
|
•
|
Delivery:
For products, delivery is considered to occur upon transfer of title and risk of loss per the respective sales terms. For rental services, delivery is considered to occur when the services are rendered.
|
|
•
|
Fixed or determinable price:
The sales price is considered fixed or determinable if it is not subject to refund or measurable adjustment.
|
|
•
|
Collection is deemed probable:
At or prior to the time of a transaction, credit reviews of each customer are performed to determine the creditworthiness of the customer. Collection is deemed probable if the customer is expected to be able to pay amounts under the arrangement as those amounts become due. If collection is not probable, revenue is recognized when collection becomes probable, generally upon cash collection.
|
Amount
|
||||
Trade receivables
|
$ | 63.2 | ||
Inventory
|
110.5 | |||
Other current assets
|
52.7 | |||
Current deferred income taxes
|
27.3 | |||
Property, plant, and equipment
|
93.2 | |||
Goodwill
|
1,203.5 | |||
Trade name (indefinite life)
|
434.0 | |||
Customer relationships (12-year useful life)
|
516.8 | |||
Developed technology (7-year weighted average useful life)
|
54.0 | |||
Other intangibles
|
19.9 | |||
Other noncurrent assets
|
30.6 | |||
Current liabilities
|
(161.5 | ) | ||
Noncurrent deferred income taxes
|
(368.7 | ) | ||
Other noncurrent liabilities
|
(25.6 | ) | ||
Total purchase price, net of cash acquired
|
$ | 2,049.9 | ||
Fair value of common stock issued
|
$ | 416.3 | ||
Cash payment, net of cash acquired
|
1,633.6 | |||
Total consideration
|
$ | 2,049.9 |
Amount
|
||||
Trade receivables
|
$ | 67.6 | ||
Inventory
|
63.6 | |||
Other current assets
|
23.4 | |||
Property, plant, and equipment
|
42.1 | |||
Goodwill
|
66.0 | |||
Trade name (5-year useful life)
|
6.7 | |||
Customer relationships (10-year weighted average useful life)
|
15.8 | |||
Developed technology (8-year weighted average useful life)
|
17.8 | |||
Other intangibles
|
4.8 | |||
Other noncurrent assets
|
0.7 | |||
Deferred tax asset
|
12.9 | |||
Current liabilities
|
(74.4 | ) | ||
Long term debt
|
(6.0 | ) | ||
Noncurrent liabilities
|
(8.1 | ) | ||
Total purchase price
|
$ | 232.9 |
|
Amount
|
|||
Inventory
|
$ | 2.6 | ||
Other current assets
|
5.4 | |||
Property, plant, and equipment
|
1.9 | |||
Goodwill
|
9.4 | |||
Current liabilities
|
(1.6 | ) | ||
Deferred tax liability
|
(0.1 | ) | ||
Total purchase price
|
$ | 17.6 |
North America
|
Surgical
and
Respiratory Care
|
International
|
Welch Allyn
|
Total
|
||||||||||||||||
Balances at September 30, 2013:
|
||||||||||||||||||||
Goodwill
|
$ | 383.0 | $ | 279.0 | $ | 153.6 | $ | - | $ | 815.6 | ||||||||||
Accumulated impairment losses
|
(358.1 | ) | - | (114.7 | ) | - | (472.8 | ) | ||||||||||||
Goodwill, net at September 30, 2013
|
24.9 | 279.0 | 38.9 | - | 342.8 | |||||||||||||||
Changes in Goodwill during the period:
|
||||||||||||||||||||
Goodwill related to acquisitions
|
7.6 | 57.3 | (2.8 | ) | - | 62.1 | ||||||||||||||
Currency translation effect
|
- | (2.8 | ) | (2.3 | ) | - | (5.1 | ) | ||||||||||||
Balances at September 30, 2014:
|
||||||||||||||||||||
Goodwill
|
390.6 | 333.5 | 148.5 | - | 872.6 | |||||||||||||||
Accumulated impairment losses
|
(358.1 | ) | - | (114.7 | ) | - | (472.8 | ) | ||||||||||||
Goodwill, net at September 30, 2014
|
32.5 | 333.5 | 33.8 | - | 399.8 | |||||||||||||||
Changes in Goodwill during the period:
|
||||||||||||||||||||
Goodwill related to acquisitions
|
- | 22.1 | - | 1,203.5 | 1,225.6 | |||||||||||||||
Currency translation effect
|
- | (11.8 | ) | (3.1 | ) | - | (14.9 | ) | ||||||||||||
Balances at September 30, 2015:
|
||||||||||||||||||||
Goodwill
|
390.6 | 343.8 | 145.4 | 1,203.5 | 2,083.3 | |||||||||||||||
Accumulated impairment losses
|
(358.1 | ) | - | (114.7 | ) | - | (472.8 | ) | ||||||||||||
Goodwill, net at September 30, 2015
|
$ | 32.5 | $ | 343.8 | $ | 30.7 | $ | 1,203.5 | $ | 1,610.5 |
September 30
|
||||||||
2015
|
2014
|
|||||||
Revolving credit facilities
|
$ | - | $ | 265.0 | ||||
Current portion of long-term debt
|
58.0 | 16.2 | ||||||
Senior secured Term Loan A, long-term portion
|
931.7 | - | ||||||
Senior secured Term Loan B, long-term portion
|
778.3 | - | ||||||
Senior unsecured 5.75% notes due on September 1, 2023
|
418.2 | - | ||||||
Term loan under August 2012 credit facility, long-term portion
|
- | 159.6 | ||||||
Unsecured 7.00% debentures due on February 15, 2024
|
13.8 | 19.2 | ||||||
Unsecured 6.75% debentures due on December 15, 2027
|
29.6 | 29.6 | ||||||
Other
|
3.6 | 1.4 | ||||||
Total debt
|
2,233.2 | 491.0 | ||||||
Less current portion of debt
|
58.0 | 126.9 | ||||||
Total long-term debt
|
$ | 2,175.2 | $ | 364.1 |
Term Loan A
|
Term Loan B
|
Total
|
||||||||||
2016
|
$ | 50.0 | $ | 8.0 | $ | 58.0 | ||||||
2017
|
$ | 75.0 | $ | 8.0 | $ | 83.0 | ||||||
2018
|
$ | 100.0 | $ | 8.0 | $ | 108.0 | ||||||
2019
|
$ | 100.0 | $ | 8.0 | $ | 108.0 | ||||||
2020
|
$ | 675.0 | $ | 8.0 | $ | 683.0 |
|
·
|
$1.0 billion senior secured Term Loan A facility (“TLA Facility”), maturing in September 2020
|
|
·
|
$800.0 million senior secured Term Loan B facility (“TLB Facility”), maturing in September 2022
|
|
·
|
Senior secured revolving credit facility (“Revolving Credit Facility”), providing borrowing capacity of up to $500.0 million, maturing in September 2020
|
|
·
|
$425.0 million of senior unsecured notes (“Senior Notes”), maturing in September 2023
|
Fiscal Quarter Ended
|
Maximum
Secured Net
Leverage Ratio
|
Minimum
Interest Coverage
Ratio
|
December 31, 2015
|
4.75x
|
3.25x
|
December 31, 2016
|
4.50x
|
3.25x
|
December 31, 2017
|
4.00x
|
3.50x
|
December 31, 2018
|
3.50x
|
3.75x
|
December 31, 2019 and thereafter
|
3.00x
|
4.00x
|
September 30
|
||||||||
2015
|
2014
|
|||||||
Senior secured Term Loan A
|
$ | 990.7 | $ | - | ||||
Senior secured Term Loan B
|
780.7 | - | ||||||
Senior unsecured 5.75% notes due on September 1, 2023
|
428.4 | - | ||||||
Term loan under August 2012 credit facility
|
- | 175.2 | ||||||
Unsecured debentures
|
43.4 | 55.5 | ||||||
Total debt
|
$ | 2,243.2 | $ | 230.7 |
Year Ended September 30, 2015
|
||||||||||||||||||||||||||||||||
Other comprehensive income (loss)
|
Accumulated other comprehensive loss
|
|||||||||||||||||||||||||||||||
Prior to
reclassification
|
Reclassification
from
|
Pre-tax
|
Tax effect
|
Net of tax
|
Beginning
balance
|
Net activity
|
Ending
balance
|
|||||||||||||||||||||||||
Available-for-sale securities
and currency hedges
|
$ | (0.6 | ) | $ | 0.6 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
Foreign currency translation
adjustment
|
(58.6 | ) | - | (58.6 | ) | - | (58.6 | ) | (34.2 | ) | (58.6 | ) | (92.8 | ) | ||||||||||||||||||
Change in pension and postretirement
defined benefit plans
|
(28.7 | ) | 15.5 | (13.2 | ) | 5.1 | (8.1 | ) | (39.9 | ) | (8.1 | ) | (48.0 | ) | ||||||||||||||||||
Total
|
$ | (87.9 | ) | $ | 16.1 | $ | (71.8 | ) | $ | 5.1 | $ | (66.7 | ) | $ | (74.1 | ) | $ | (66.7 | ) | $ | (140.8 | ) |
Year Ended September 30, 2014
|
||||||||||||||||||||||||||||||||
Other comprehensive income (loss)
|
Accumulated other comprehensive loss
|
|||||||||||||||||||||||||||||||
Prior to
reclassification
|
Reclassification
from
|
Pre-tax
|
Tax effect
|
Net of tax
|
Beginning
balance
|
Net activity
|
Ending
balance
|
|||||||||||||||||||||||||
Available-for-sale securities
and currency hedges
|
$ | 0.3 | $ | 0.1 | $ | 0.4 | $ | (0.1 | ) | $ | 0.3 | $ | (0.3 | ) | $ | 0.3 | $ | - | ||||||||||||||
Foreign currency translation
adjustment
|
(29.6 | ) | - | (29.6 | ) | - | (29.6 | ) | (4.6 | ) | (29.6 | ) | (34.2 | ) | ||||||||||||||||||
Change in pension and postretirement
defined benefit plans
|
(16.8 | ) | 2.7 | (14.1 | ) | 5.0 | (9.1 | ) | (30.8 | ) | (9.1 | ) | (39.9 | ) | ||||||||||||||||||
Total
|
$ | (46.1 | ) | $ | 2.8 | $ | (43.3 | ) | $ | 4.9 | $ | (38.4 | ) | $ | (35.7 | ) | $ | (38.4 | ) | $ | (74.1 | ) |
Years Ended September 30
|
||||||||||||||||||||||||
2015
|
2014
|
|||||||||||||||||||||||
Amount
reclassified
|
Tax effect
|
Net of tax
|
Amount
reclassified
|
Tax effect
|
Net of tax
|
|||||||||||||||||||
Change in pension and postretirement
defined benefit plans (1)
|
$ | 15.5 | $ | (5.6 | ) | $ | 9.9 | $ | 2.7 | $ | (1.0 | ) | $ | 1.7 | ||||||||||
Available-for-sale securities
and currency hedges (2)
|
$ | 0.6 | $ | (0.2 | ) | $ | 0.4 | $ | 0.1 | $ | - | $ | 0.1 |
(1) Reclassified from accumulated other comprehensive loss into cost of goods sold and selling and administrative expenses.
|
These components are included in the computation of net periodic pension and postretirement benefit expense.
|
(2) Reclassified from accumulated other comprehensive loss into other income (expense), net.
|
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Service cost
|
$ | 5.4 | $ | 5.0 | $ | 6.1 | ||||||
Interest cost
|
14.6 | 14.4 | 13.2 | |||||||||
Expected return on plan assets
|
(16.7 | ) | (16.7 | ) | (15.9 | ) | ||||||
Amortization of unrecognized prior service cost, net
|
0.6 | 0.6 | 0.6 | |||||||||
Amortization of net loss
|
5.2 | 3.2 | 7.8 | |||||||||
Net periodic benefit cost
|
9.1 | 6.5 | 11.8 | |||||||||
Settlement charge
|
9.6 | - | - | |||||||||
Special termination benefits
|
- | 2.4 | - | |||||||||
Net pension expense
|
$ | 18.7 | $ | 8.9 | $ | 11.8 |
Years Ended September 30
|
||||||||
2015
|
2014
|
|||||||
Change in benefit obligation:
|
||||||||
Benefit obligation at beginning of year
|
$ | 343.8 | $ | 297.9 | ||||
Service cost
|
5.4 | 5.0 | ||||||
Interest cost
|
14.6 | 14.4 | ||||||
Actuarial loss
|
12.5 | 31.4 | ||||||
Benefits paid
|
(54.0 | ) | (10.2 | ) | ||||
Acquisitions
|
- | 4.3 | ||||||
Special termination benefits
|
- | 2.4 | ||||||
Plan settlement
|
(4.4 | ) | - | |||||
Exchange rate gain
|
(2.4 | ) | (1.4 | ) | ||||
Benefit obligation at end of year
|
315.5 | 343.8 | ||||||
Change in plan assets:
|
||||||||
Fair value of plan assets at beginning of year
|
276.1 | 254.4 | ||||||
Actual return on plan assets
|
(3.9 | ) | 30.9 | |||||
Employer contributions
|
0.9 | 1.0 | ||||||
Benefits paid
|
(54.0 | ) | (10.2 | ) | ||||
Fair value of plan assets at end of year
|
219.1 | 276.1 | ||||||
Funded status and net amounts recognized
|
$ | (96.4 | ) | $ | (67.7 | ) | ||
Amounts recorded in the Consolidated Balance Sheets:
|
||||||||
Accrued pension benefits, current portion
|
$ | (1.0 | ) | $ | (1.0 | ) | ||
Accrued pension benefits, long-term
|
(95.4 | ) | (66.7 | ) | ||||
Net amount recognized
|
$ | (96.4 | ) | $ | (67.7 | ) |
September 30
|
||||||||||||||||||||||||
2015
|
2014
|
|||||||||||||||||||||||
PBO
|
ABO
|
Plan Assets
|
PBO
|
ABO
|
Plan Assets
|
|||||||||||||||||||
Master plan
|
$ | 292.5 | $ | 275.3 | $ | 218.9 | $ | 319.1 | $ | 303.2 | $ | 275.8 | ||||||||||||
International plans
|
17.9 | 16.3 | 0.2 | 20.3 | 18.5 | 0.3 | ||||||||||||||||||
Supplemental executive plan
|
5.1 | 5.1 | - | 4.4 | 4.2 | - | ||||||||||||||||||
$ | 315.5 | $ | 296.7 | $ | 219.1 | $ | 343.8 | $ | 325.9 | $ | 276.1 |
2015
|
2014
|
2013
|
||||
Weighted average assumptions to determine benefit
|
||||||
obligations at the measurement date:
|
||||||
Discount rate for obligation
|
4.4%
|
4.5%
|
5.0%
|
|||
Rate of compensation increase
|
3.0%
|
3.0%
|
3.3%
|
|||
Weighted average assumptions to determine benefit
|
||||||
cost for the year:
|
||||||
Discount rate for expense
|
4.5%
|
5.0%
|
4.1%
|
|||
Expected rate of return on plan assets
|
6.8%
|
7.0%
|
7.0%
|
|||
Rate of compensation increase
|
3.0%
|
3.3%
|
3.3%
|
2015
|
2014
|
2015
|
2014
|
||||
Target
|
Target
|
Actual
|
Actual
|
||||
Allocation
|
Allocation
|
Allocation
|
Allocation
|
||||
Equity securities
|
39 - 49%
|
40 - 60%
|
42%
|
52%
|
|||
Fixed income securities
|
51 - 61%
|
40 - 60%
|
58%
|
48%
|
|||
Total
|
100%
|
100%
|
Quoted Prices in
|
Significant
|
|||||||||||||||
Active Markets
|
Other
|
Significant
|
||||||||||||||
for Identical
|
Observable
|
Unobservable
|
||||||||||||||
Balance at
|
Assets
|
Inputs
|
Inputs
|
|||||||||||||
|
September 30, 2015
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
||||||||||||
Cash
|
$ | 3.5 | $ | 3.5 | $ | - | $ | - | ||||||||
Equities
|
||||||||||||||||
U.S. companies
|
47.1 | - | 47.1 | - | ||||||||||||
International companies
|
44.8 | - | 44.8 | - | ||||||||||||
Fixed income securities
|
123.7 | - | 123.7 | - | ||||||||||||
Total plan assets at fair value
|
$ | 219.1 | $ | 3.5 | $ | 215.6 | $ | - |
Quoted Prices in
|
Significant
|
|||||||||||||||
Active Markets
|
Other
|
Significant
|
||||||||||||||
for Identical
|
Observable
|
Unobservable
|
||||||||||||||
Balance at
|
Assets
|
Inputs
|
Inputs
|
|||||||||||||
|
September 30, 2014
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
||||||||||||
Cash
|
$ | 2.1 | $ | 2.1 | $ | - | $ | - | ||||||||
Equities
|
||||||||||||||||
U.S. companies
|
101.7 | 101.7 | - | - | ||||||||||||
International companies
|
38.7 | 38.7 | - | - | ||||||||||||
Fixed income securities
|
133.2 | 66.8 | 66.4 | - | ||||||||||||
Other
|
0.4 | 0.4 | - | - | ||||||||||||
Total plan assets at fair value
|
$ | 276.1 | $ | 209.7 | $ | 66.4 | $ | - |
Pension Benefits
|
||||
2016
|
$ | 12.3 | ||
2017
|
$ | 12.8 | ||
2018
|
$ | 13.3 | ||
2019
|
$ | 14.0 | ||
2020
|
$ | 14.8 | ||
2021-2025
|
$ | 86.5 |
Years Ended September 30
|
||||||||
2015
|
2014
|
|||||||
Change in benefit obligation:
|
||||||||
Benefit obligation at beginning of year
|
$ | 11.2 | $ | 9.8 | ||||
Service cost
|
0.4 | 0.4 | ||||||
Interest cost
|
0.4 | 0.4 | ||||||
Acquired obligation
|
14.1 | - | ||||||
Actuarial gain
|
(0.9 | ) | (0.2 | ) | ||||
Benefits paid
|
(0.2 | ) | (0.2 | ) | ||||
Retiree contributions
|
0.1 | 0.2 | ||||||
Special termination benefits
|
- | 0.8 | ||||||
Benefit obligation at end of year
|
$ | 25.1 | $ | 11.2 | ||||
Amounts recorded in the Consolidated Balance Sheets:
|
||||||||
Accrued benefits obligation, current portion
|
$ | 1.8 | $ | 1.1 | ||||
Accrued benefits obligation, long-term
|
23.3 | 10.1 | ||||||
Net amount recognized
|
$ | 25.1 | $ | 11.2 |
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Total stock-based compensation cost (pre-tax)
|
$ | 25.0 | $ | 18.0 | $ | 13.5 | ||||||
Total income tax benefit
|
(7.5 | ) | (6.5 | ) | (4.9 | ) | ||||||
Total stock-based compensation cost, net of tax
|
$ | 17.5 | $ | 11.5 | $ | 8.6 |
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Weighted average fair value per share
|
$ | 12.83 | $ | 11.91 | $ | 7.91 | ||||||
Valuation assumptions:
|
||||||||||||
Risk-free interest rate
|
1.6% | 1.3% | 0.6% | |||||||||
Expected dividend yield
|
1.4% | 1.4% | 1.9% | |||||||||
Expected volatility
|
35.0% | 36.1% | 40.2% | |||||||||
Weighted average expected life
|
4.9 years
|
4.9 years
|
4.9 years
|
Weighted
|
Weighted
|
||||||||||||
Average
|
Weighted
|
Average
|
Aggregate
|
||||||||||
Number of
|
Average
|
Remaining
|
Intrinsic
|
||||||||||
Shares
|
Exercise
|
Contractual
|
Value (1)
|
||||||||||
(in thousands)
|
Price
|
Term
|
(in millions)
|
||||||||||
Balance Outstanding at October 1, 2014
|
1,992 | $ | 31.99 | ||||||||||
Granted
|
381 | 45.01 | |||||||||||
Exercised
|
(371 | ) | 31.83 | ||||||||||
Cancelled/Forfeited
|
(101 | ) | 36.63 | ||||||||||
Balance Outstanding at September 30, 2015
|
1,901 | $ | 34.38 |
6.6 years
|
$ | 33.5 | |||||||
Exercisable at September 30, 2015
|
1,060 | $ | 30.98 |
5.3 years
|
$ | 22.3 | |||||||
Options Expected to Vest
|
773 | $ | 38.34 |
8.0 years
|
$ | 10.6 |
(1)
|
The aggregate intrinsic value represents the total pre-tax intrinsic value, based on our closing stock price of $51.99, as reported by the New York Stock Exchange on September 30, 2015. This amount, which changes continuously based on the fair value of our common stock, would have been received by the option holders had all option holders exercised their options as of the balance sheet date.
|
Weighted
|
||||||||
Number of
|
Average
|
|||||||
Share Units
|
Grant Date
|
|||||||
(in thousands)
|
Fair Value
|
|||||||
Nonvested RSUs at October 1, 2014
|
431 | $ | 34.92 | |||||
Granted
|
351 | 47.85 | ||||||
Vested
|
(93 | ) | 37.76 | |||||
Forfeited
|
(55 | ) | 35.90 | |||||
Nonvested RSUs at September 30, 2015
|
634 | $ | 41.35 |
Years Ended September 30
|
||||||
2015
|
2014
|
2013
|
||||
Weighted average fair value per share
|
$47.82
|
$47.91
|
$19.77
|
|||
Valuation assumptions:
|
||||||
Risk-free interest rate
|
0.9%
|
0.5%
|
0.3%
|
|||
Expected dividend yield
|
0.0%
|
0.0%
|
0.0%
|
|||
Expected volatility
|
23.5%
|
30.1%
|
32.6%
|
Weighted
|
||||||||
Number of
|
Average
|
|||||||
Share Units
|
Grant Date
|
|||||||
(in thousands)
|
Fair Value
|
|||||||
Nonvested PSUs as of October 1, 2014
|
586 | $ | 29.98 | |||||
Granted
|
331 | 49.27 | ||||||
Vested
|
(414 | ) | 30.11 | |||||
Cancelled
|
(76 | ) | 24.57 | |||||
Forfeited
|
(73 | ) | 41.15 | |||||
Nonvested PSUs at September 30, 2015
|
354 | $ | 42.16 |
Balance at September 30, 2014
|
$ | 11.7 | ||
Expenses
|
23.1 | |||
Cash Payments
|
(10.0 | ) | ||
Reversals
|
(0.5 | ) | ||
Balance at September 30, 2015
|
$ | 24.3 |
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Income before income taxes:
|
||||||||||||
Domestic
|
$ | 49.2 | $ | 87.0 | $ | 120.0 | ||||||
Foreign
|
15.9 | 28.2 | 24.0 | |||||||||
Total
|
$ | 65.1 | $ | 115.2 | $ | 144.0 | ||||||
Income tax expense:
|
||||||||||||
Current provision
|
||||||||||||
Federal
|
$ | 35.3 | $ | 40.2 | $ | 45.0 | ||||||
State
|
3.6 | 3.1 | 1.8 | |||||||||
Foreign
|
1.7 | 7.4 | 7.0 | |||||||||
Total current provision
|
40.6 | 50.7 | 53.8 | |||||||||
Deferred provision:
|
||||||||||||
Federal
|
(18.1 | ) | (12.2 | ) | (9.9 | ) | ||||||
State
|
(1.3 | ) | (1.0 | ) | 1.1 | |||||||
Foreign
|
(2.9 | ) | 17.1 | (6.0 | ) | |||||||
Total deferred provision
|
(22.3 | ) | 3.9 | (14.8 | ) | |||||||
Income tax expense
|
$ | 18.3 | $ | 54.6 | $ | 39.0 |
Years Ended September 30
|
||||||||||||||||||||||||
2015
|
2014
|
2013
|
||||||||||||||||||||||
% of | % of | % of | ||||||||||||||||||||||
Pretax
|
Pretax
|
Pretax
|
||||||||||||||||||||||
Amount
|
Income
|
Amount
|
Income
|
Amount
|
Income
|
|||||||||||||||||||
Federal income tax
(a)
|
$ | 22.8 | 35.0 | $ | 40.3 | 35.0 | $ | 50.4 | 35.0 | |||||||||||||||
State income tax
(b)
|
1.6 | 2.4 | 2.0 | 1.7 | 2.5 | 1.7 | ||||||||||||||||||
Foreign income tax
(c)
|
(10.2 | ) | (15.7 | ) | (7.7 | ) | (6.7 | ) | (5.7 | ) | (4.0 | ) | ||||||||||||
Application of federal tax credits
|
(2.2 | ) | (3.4 | ) | (0.6 | ) | (0.5 | ) | (3.5 | ) | (2.4 | ) | ||||||||||||
Adjustment of estimated income tax accruals
|
(1.6 | ) | (2.4 | ) | (0.6 | ) | (0.5 | ) | (1.5 | ) | (1.0 | ) | ||||||||||||
Valuation of tax attributes
|
4.0 | 6.2 | 21.3 | 18.5 | 0.6 | 0.4 | ||||||||||||||||||
Domestic manufacturer's deduction
|
(1.5 | ) | (2.3 | ) | (1.8 | ) | (1.5 | ) | (2.2 | ) | (1.5 | ) | ||||||||||||
Capitalized transaction costs
|
2.5 | 3.8 | 0.3 | 0.2 | - | - | ||||||||||||||||||
Other, net
|
2.9 | 4.5 | 1.4 | 1.2 | (1.6 | ) | (1.1 | ) | ||||||||||||||||
Income tax expense
|
$ | 18.3 | 28.1 | $ | 54.6 | 47.4 | $ | 39.0 | 27.1 |
(a)
|
At statutory rate.
|
(b)
|
Net of Federal benefit.
|
(c)
|
Federal tax rate differential.
|
Years Ended September 30
|
||||||||
2015
|
2014
|
|||||||
Deferred tax assets:
|
||||||||
Employee benefit accruals
|
$ | 106.4 | $ | 49.3 | ||||
Inventory
|
6.2 | 13.9 | ||||||
Reserve for bad debts
|
8.4 | 10.0 | ||||||
Net operating loss carryforwards
|
45.8 | 40.3 | ||||||
Tax credit carryforwards
|
11.7 | 2.5 | ||||||
Other, net
|
39.6 | 25.7 | ||||||
218.1 | 141.7 | |||||||
Less: Valuation allowance
|
(40.7 | ) | (28.3 | ) | ||||
Total deferred tax assets
|
177.4 | 113.4 | ||||||
Deferred tax liabilities:
|
||||||||
Depreciation
|
(35.3 | ) | (13.9 | ) | ||||
Amortization
|
(409.1 | ) | (62.8 | ) | ||||
Other, net
|
(16.4 | ) | (4.9 | ) | ||||
Total deferred tax liabilities
|
(460.8 | ) | (81.6 | ) | ||||
Deferred tax asset (liability) - net
|
$ | (283.4 | ) | $ | 31.8 |
Years Ended September 30
|
|||||||||||
2015
|
2014
|
2013
|
|||||||||
Balance at October 1
|
$ | 4.1 | $ | 4.6 | $ | 9.8 | |||||
Increases in tax position of prior years
|
0.4 | 2.1 | - | ||||||||
Decreases in tax position of prior years
|
(1.3 | ) | (0.9 | ) | (0.5 | ) | |||||
Increases in tax positions related to the current year | - | - | 0.1 | ||||||||
Settlements with taxing authorities
|
(1.2 | ) | (0.1 | ) | (3.2 | ) | |||||
Lapse of applicable statute of limitations
|
(1.3 | ) | (1.5 | ) | (1.7 | ) | |||||
Increase in positions due to acquisitions
|
5.5 | - | - | ||||||||
Foreign currency adjustments
|
(0.4 | ) | (0.1 | ) | 0.1 | ||||||
Total change
|
1.7 | (0.5 | ) | (5.2 | ) | ||||||
Balance at September 30
|
$ | 5.8 | $ | 4.1 | $ | 4.6 |
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Net income attributable to common shareholders
|
$ | 47.7 | $ | 60.6 | $ | 105.0 | ||||||
Average shares outstanding - Basic (thousands)
|
57,249 | 57,555 | 59,910 | |||||||||
Add potential effect of exercise of stock options
|
||||||||||||
and other unvested equity awards (thousands)
|
1,287 | 968 | 340 | |||||||||
Average shares outstanding - Diluted (thousands)
|
58,536 | 58,523 | 60,250 | |||||||||
Net income attributable to common shareholders per common share - Basic
|
$ | 0.83 | $ | 1.05 | $ | 1.75 | ||||||
Net income attributable to common shareholders per common share - Diluted
|
$ | 0.82 | $ | 1.04 | $ | 1.74 |
|
·
|
North America -
sells and rents our patient support and near-patient technologies and services, as well as our health information technology solutions, in the U.S. and Canada.
|
|
·
|
Surgical and Respiratory Care -
sells and rents our surgical and respiratory care products globally
.
|
|
·
|
International -
sells and rents similar products as our North America segment in regions outside of the U.S. and Canada.
|
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Revenue:
|
||||||||||||
North America
|
$ | 1,002.0 | $ | 888.9 | $ | 958.3 | ||||||
Surgical and Respiratory Care
|
506.6 | 301.6 | 245.8 | |||||||||
International
|
429.4 | 495.6 | 512.1 | |||||||||
Welch Allyn
1
|
50.2 | - | - | |||||||||
Total revenue
|
$ | 1,988.2 | $ | 1,686.1 | $ | 1,716.2 | ||||||
Divisional income:
|
||||||||||||
North America
|
$ | 204.1 | $ | 165.0 | $ | 201.7 | ||||||
Surgical and Respiratory Care
|
80.5 | 68.6 | 56.8 | |||||||||
International
|
12.8 | 24.9 | 33.5 | |||||||||
Other:
|
||||||||||||
Non-allocated operating costs, administrative costs, and other
|
173.1 | 98.8 | 131.4 | |||||||||
Special charges
|
41.2 | 37.1 | 5.7 | |||||||||
Operating profit
|
83.1 | 122.6 | 154.9 | |||||||||
Interest expense
|
(18.4 | ) | (9.8 | ) | (9.5 | ) | ||||||
Investment income and other, net
|
0.4 | 2.4 | (1.4 | ) | ||||||||
Income before income taxes
|
$ | 65.1 | $ | 115.2 | $ | 144.0 |
Years Ended September 30
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Net revenue to unaffiliated customers:
(a)
|
||||||||||||
United States
|
$ | 1,273.0 | $ | 1,070.8 | $ | 1,116.4 | ||||||
Foreign
|
715.2 | 615.3 | 599.8 | |||||||||
Total revenue
|
$ | 1,988.2 | $ | 1,686.1 | $ | 1,716.2 | ||||||
Long-lived assets:
(b)
|
||||||||||||
United States
|
$ | 263.9 | $ | 151.7 | $ | 158.0 | ||||||
Foreign
|
114.5 | 109.8 | 76.3 | |||||||||
Total long-lived assets
|
$ | 378.4 | $ | 261.5 | $ | 234.3 |
(a)
|
Net revenue is attributed to geographic areas based on the location of the customer.
|
(b)
|
Includes property and equipment leased to others.
|
2015 Quarter Ended
|
December 31,
2014
|
March 31,
2015
|
June 30,
2015
|
September 30,
2015
|
||||||||||||
Net revenue
|
$ | 465.0 | $ | 474.8 | $ | 474.5 | $ | 573.9 | ||||||||
Gross profit
|
$ | 199.9 | $ | 214.2 | $ | 209.5 | $ | 256.7 | ||||||||
Net income (loss) attributable to common shareholders
|
$ | 12.1 | $ | 26.1 | $ | 19.1 | $ | (9.6 | ) | |||||||
Basic net income (loss) attributable to common
shareholders per common share
|
$ | 0.21 | $ | 0.46 | $ | 0.34 | $ | (0.16 | ) | |||||||
Diluted net income (loss) attributable to common
shareholders per common share
|
$ | 0.21 | $ | 0.45 | $ | 0.33 | $ | (0.16 | ) |
2014 Quarter Ended
|
December 31,
2013
|
March 31,
2014
|
June 30,
2014
|
September 30,
2014
|
||||||||||||
Net revenue
|
$ | 393.4 | $ | 415.3 | $ | 397.6 | $ | 479.8 | ||||||||
Gross profit
|
$ | 176.8 | $ | 202.7 | $ | 187.1 | $ | 213.3 | ||||||||
Net income (loss) attributable to common shareholders
|
$ | 13.2 | $ | (3.3 | ) | $ | 26.1 | $ | 24.6 | |||||||
Basic net income (loss) attributable to common
shareholders per common share
|
$ | 0.23 | $ | (0.06 | ) | $ | 0.46 | $ | 0.43 | |||||||
Diluted net income (loss) attributable to common
shareholders per common share
|
$ | 0.22 | $ | (0.06 | ) | $ | 0.45 | $ | 0.42 |
Amount
|
||||
2016
|
$ | 28.2 | ||
2017
|
$ | 18.4 | ||
2018
|
$ | 12.1 | ||
2019
|
$ | 6.3 | ||
2020
|
$ | 3.2 | ||
2021 and beyond
|
$ | 5.6 |
Item 9A.
|
CONTR
OLS AND PROCEDURES
|
Item 10.
|
DIREC
TORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
Item 11.
|
E
XEC
UTIVE COMPENSATION
|
Item 12.
|
SECU
RITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS
|
Item 13.
|
CERTAIN
RELA
TIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR
INDEPENDENCE
|
Item 14.
|
PRINC
IPAL ACCOUNTING FEES AND SERVICES
|
Item 15.
|
EXHIB
ITS AND FINANCIAL STATEMENT SCHEDULES
|
(a)
|
The following documents have been filed as a part of this Form 10-K or, where noted, incorporated by reference:
|
|
(1)
|
Financial Statements
|
|
(2)
|
Financial Statement Schedules
|
|
(3)
|
Exhibits (See changes to Exhibit Index below):
|
|
·
|
should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
|
|
·
|
may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;
|
|
·
|
may apply standards of materiality in a way that is different from what may be viewed as material to certain investors; and
|
|
·
|
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
|
ADDITIONS
|
||||||||||||||||||||||
BALANCE AT
|
CHARGED TO
|
CHARGED TO
|
DEDUCTIONS
|
BALANCE
|
||||||||||||||||||
BEGINNING
|
COSTS AND
|
OTHER
|
NET OF
|
AT END
|
||||||||||||||||||
DESCRIPTION
|
OF PERIOD
|
EXPENSES
|
ACCOUNTS
|
RECOVERIES
|
OF PERIOD
|
|||||||||||||||||
Reserves deducted from assets to which they apply:
|
||||||||||||||||||||||
Allowance for possible losses and sales returns -
|
||||||||||||||||||||||
accounts receivable:
|
||||||||||||||||||||||
Period Ended:
|
||||||||||||||||||||||
September 30, 2015
|
$ | 31.4 | $ | 1.8 | $ | 0.1 |
(a)
|
$ | (7.3 | ) |
(b)
|
$ | 26.0 | |||||||||
September 30, 2014
|
$ | 30.1 | $ | 1.5 | $ | 8.6 |
(a)
|
$ | (8.8 | ) |
(b)
|
$ | 31.4 | |||||||||
September 30, 2013
|
$ | 38.5 | $ | 2.7 | $ | (0.1 | ) |
(a)
|
$ | (11.0 | ) |
(b)
|
$ | 30.1 | ||||||||
Allowance for inventory valuation:
|
||||||||||||||||||||||
Period Ended:
|
||||||||||||||||||||||
September 30, 2015
|
$ | 42.9 | $ | 0.9 | $ | 5.7 |
(c)
|
$ | (4.0 | ) |
(d)
|
$ | 45.5 | |||||||||
September 30, 2014
|
$ | 22.0 | $ | 4.0 | $ | 19.8 |
(c)
|
$ | (2.9 | ) |
(d)
|
$ | 42.9 | |||||||||
September 30, 2013
|
$ | 22.0 | $ | 1.8 | $ | - | $ | (1.8 | ) |
(d)
|
$ | 22.0 | ||||||||||
Valuation allowance against deferred tax assets:
|
||||||||||||||||||||||
Period Ended:
|
||||||||||||||||||||||
September 30, 2015
|
$ | 28.3 | $ | 4.0 | $ | 11.1 |
(c)
|
$ | (2.7 | ) |
(e)
|
$ | 40.7 | |||||||||
September 30, 2014
|
$ | 8.9 | $ | 21.3 | $ | - | $ | (1.9 | ) |
(e)
|
$ | 28.3 | ||||||||||
September 30, 2013
|
$ | 8.6 | $ | 0.6 | $ | - | $ | (0.3 | ) |
(e)
|
$ | 8.9 |
(a)
|
Reduction of gross revenue for uncollectible health care rental reimbursements, cash discounts and other adjustments in determining
|
||||||||||||
net revenue. Also includes the effect of acquired businesses, if any.
|
|||||||||||||
(b)
|
Generally reflects the write-off of specific receivables against recorded reserves.
|
||||||||||||
(c)
|
Generally reflects the effect of acquired businesses, if any.
|
||||||||||||
(d)
|
Generally reflects the write-off of specific inventory against recorded reserves.
|
||||||||||||
(e)
|
Primarily reflects write-offs of deferred tax assets against the valuation allowance and other movement of the valuation allowance
|
||||||||||||
offset by an opposing change in deferred tax assets.
|
HILL-ROM HOLDINGS, INC.
|
|||
By:
|
/s/ John J. Greisch | ||
John J. Greisch
|
|||
President and Chief Executive Officer
|
/s/
Rolf A. Classon
|
/s/
James R. Giertz
|
|
Rolf A. Classon
Chairman of the Board
|
James R. Giertz
Director
|
|
/s/
John J. Greisch
|
/s/
Charles E. Golden
|
|
John J. Greisch
President and Chief Executive Officer and Director
(Principal Executive Officer)
|
Charles E. Golden
Director
|
|
/s/
Steven J. Strobel
|
/s/
William H. Kucheman
|
|
Steven J. Strobel
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
|
William H. Kucheman
Director
|
|
/s/
Richard G. Keller
|
/s/
Ronald A. Malone
|
|
Richard G. Keller
Vice President — Controller and
Chief Accounting Officer
(Principal Accounting Officer)
|
Ronald A. Malone
Director
|
|
/s/
William G. Dempsey.
|
/s/
Eduardo R. Menascé
|
|
William G. Dempsey
Director
|
Eduardo R. Menascé
Director
|
|
|
|
|
|
Stacy Enxing Seng
Director
|
|
2.1
|
Agreement and Plan of Merger dated June 16, 2015 by and among Hill-Rom Holdings, Inc., Empire Merger Sub Corp., and Welch Allyn Holdings, Inc. (Incorporated herein by reference to Exhibit 2.1 filed with the Form 8-K dated June 17, 2015)
|
2.2
|
Share Purchase and Transfer Agreement dated as of June 13, 2014 by and among TRUMPF International Beteiligungs-GmbH, Hill-Rom Holdings Netherlands B.V., HR Europe B.V. and Hill-Rom Holdings, Inc. (Incorporated herein by reference to Exhibit 1.1 filed with Form 8-K dated June 16, 2014)
|
3.1
|
Restated and Amended Articles of Incorporation of Hill-Rom Holdings, Inc., as currently in effect (Incorporated herein by reference to Exhibit 3.1 filed with Form 8-K dated March 10, 2010)
|
3.2
|
Amended and Restated Code of By-Laws of Hill-Rom Holdings, Inc., as currently in effect (Incorporated herein by reference to Exhibit 3.2 filed with Form 8-K dated March 10, 2010)
|
4.1
|
Indenture dated as of December 1, 1991, between Hill-Rom Holdings, Inc. and Union Bank, N.A. (as successor to LaSalle Bank National Association and Harris Trust and Savings Bank) as Trustee (Incorporated herein by reference to Exhibit (4) (a) to Registration Statement on Form S-3, Registration No. 33-44086)
|
4.2
|
Indenture dated as of September 1, 2015, between Hill-Rom Holdings, Inc. and MUFG Union Bank, N.A., as Trustee (Incorporated herein by reference to Exhibit 10.1 to the Form 8-K dated September 8, 2015)
|
*10.1
|
Hill-Rom Holdings, Inc. Amended and Restated Short Term Incentive Compensation Program (Incorporated herein by reference to Exhibit 10.1 filed with Form 10-K dated November 24, 2009)
|
*10.2
|
Form of Director Indemnity Agreement (Incorporated herein by reference to Exhibit 10.6 filed with Form 10-K dated December 23, 2003)
|
*10.3
|
Form of Indemnity Agreement between Hill-Rom Holdings, Inc. and certain executive officers (Incorporated herein by reference to Exhibit 10.6 filed with Form 10-K dated November 16, 2011)
|
*10.4
|
Hill-Rom Holdings, Inc. Board of Directors’ Deferred Compensation Plan (Incorporated herein by reference to Exhibit 10.10 filed with Form 10-Q dated July 13, 2001)
|
*10.5
|
Hill-Rom Holdings, Inc. Director Phantom Stock Plan and form of award (Incorporated herein by reference to Exhibit 10.11 filed with Form 10-Q dated July 13, 2001)
|
*10.6
|
Form of Non-Qualified Stock Option Agreement under Amended and Restated Hill-Rom Holdings, Inc. Stock Incentive Plan (Incorporated herein by reference to Exhibit 10.11 filed with Form 10-K dated November 16, 2011)
|
*10.7
|
Form of Non-Qualified Stock Option Agreement (CEO version) under Amended and Restated Hill-Rom Holdings, Inc. Stock Incentive Plan (Incorporated herein by reference to Exhibit 10.12 filed with Form 10-K dated November 16, 2011)
|
*10.8
|
Amended and Restated Hill-Rom Holdings, Inc. Stock Incentive Plan, as currently in effect (Incorporated herein by reference to Exhibit 10.30 filed with Form 10-K dated November 24, 2009)
|
*10.9
|
Employment Agreement dated as of March 31, 2008 between Hill-Rom Company, Inc. and Richard G. Keller (Incorporated herein by reference to Exhibit 10.12 filed with Form 10-Q dated May 14, 2008)
|
*10.10
|
Hill-Rom Holdings, Inc. Employee Stock Purchase Plan (Incorporated by reference to Appendix I to the Company’s definitive Proxy Statement on Schedule 14A dated January 7, 2009)
|
*10.11
|
Employment Agreement dated January 6, 2010 between Hill-Rom Holdings, Inc. and John J. Greisch (Incorporated herein by reference to Exhibit 10.1 filed with Form 8-K dated January 7, 2010)
|
*10.12
|
Employment Agreement between Hill-Rom Holdings, Inc. and Susan R. Lichtenstein dated May 10, 2010 (Incorporated herein by reference to Exhibit 10.7 filed with Form 10-Q dated May 6, 2010)
|
*10.13
|
Form of Change in Control Agreement between Hill-Rom Holdings, Inc. and certain of its officers, including Named Executive Officers (other than the CEO) (Incorporated by reference to Exhibit 10.58 filed with the Company’s Form 10-K dated November 17, 2010)
|
*10.14
|
Amended Change in Control Agreement between Hill-Rom Holdings, Inc. and John J. Greisch dated September 30, 2010 (Incorporated by reference to Exhibit 10.59 filed with the Company’s Form 10-K dated November 17, 2010)
|
*10.15
|
2014 Non-Employee Director Compensation Policy
|
*10.16
|
Form of Restricted Stock Unit Agreement under Amended and Restated Hill-Rom Holdings, Inc. Stock Incentive Plan (Incorporated by reference to Exhibit 10.63 filed with the Company’s Form 10-K dated November 17, 2010)
|
*10.17
|
Form of Restricted Stock Unit Agreement (CEO version) under Amended and Restated Hill-Rom Holdings, Inc. Stock Incentive Plan (Incorporated by reference to Exhibit 10.65 filed with the Company’s Form 10-K dated November 17, 2010)
|
*10.18
|
FY 2011 Form of Performance Based Stock Award under the Stock Incentive Plan (Incorporated by reference to Exhibit 10.61 filed with the Company’s Form 10-K dated November 16, 2011)
|
*10.19
|
FY 2011 Form of Performance Based Stock Award under the Stock Incentive Plan (CEO version) (Incorporated by reference to Exhibit 10.62 filed with the Company’s Form 10-K dated November 16, 2011)
|
*10.20
|
Hill-Rom Holdings, Inc. Short-Term Incentive Plan (Incorporated by reference to Appendix 1 to the Hill-Rom Holdings, Inc. Definitive Proxy Statement on Schedule 14A dated January 18, 2011)
|
*10.21
|
Hill-Rom Holdings, Inc. Amended and Restated Supplemental Executive Retirement Plan (Incorporated by reference to Exhibit 10.69 filed with the Company’s Form 10-K dated November 16, 2011)
|
*10.22
|
Employment Agreement between Hill-Rom Holdings, Inc. and Alton Shader, dated July 11, 2011 (Incorporated by reference to Exhibit 10.2 filed with the Company’s Form 10-Q dated July 28, 2011)
|
*10.23
|
Employment Agreement between Hill-Rom Holdings, Inc. and Andreas Frank, dated October 3, 2011 (Incorporated by reference to Exhibit 10.72 filed with the Company’s Form 10-K dated November 16, 2011)
|
*10.24
|
Employment Agreement between Hill-Rom Holdings, Inc. and Carlyn Solomon, dated October 3, 2014 (Incorporated by reference to Exhibit 10.1 filed with the Company’s Form 8-K dated October 9, 2014)
|
*10.25
|
Employment Agreement between Hill-Rom Holdings, Inc. and Steven Strobel, dated October 23, 2014 (Incorporated by reference to Exhibit 10.1 filed with the Company’s Form 8-K dated October 27, 2014)
|
10.26
|
Credit Agreement dated as of September 8, 2015 among Hill-Rom Holdings, Inc., the lenders named therein, and JPMorgan Chase Bank N.A. as Term Loan A agent for the lenders and Goldman Sachs Bank USA as Term Loan B agent for the lenders (Incorporated herein by reference to Exhibit 10.1 to the Form 8-K dated September 8, 2015)
|
*10.27
|
Form of Limited Recapture Agreement between Hill-Rom Holdings, Inc. and certain of its officers, including Named Executive Officers (Incorporated by reference to Exhibit 10.34 filed with the Company’s Form 10-K dated November 20, 2013)
|
*10.28
|
Employment Agreement between Hill-Rom Holdings, Inc. and Carlos Alonso-Marum dated March 19, 2015 (Incorporated herein by reference to Exhibit 10.2 to the Form 10-Q dated August 7, 2015)
|
*10.29
|
Employment Agreement between Hill-Rom Holdings, Inc. and Kenneth Meyers dated September 23, 2015
|
*10.30
|
Employment Agreement between Hill-Rom Holdings, Inc. and Taylor Smith dated November 11, 2013
|
10.31
|
FY 2016 Non-Employee Director Compensation Policy
|
21
|
Subsidiaries of the Registrant
|
23
|
Consent of Independent Registered Public Accounting Firm
|
31.1
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32.1
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
32.2
|
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
101.INS XBRL Instance Document
|
101.SCH XBRL Taxonomy Extension Schema Document
|
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
|
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
|
101.LAB XBRL Extension Labels Linkbase Document
|
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
|
1.
|
Employment
. As of Executive’s first date of employment with the Company (“
Start Date
”), as mutually agreed upon by the Company and Executive, the Executive agrees to serve as Senior Vice President, Administration and Chief Human Resources Officer of the Company, reporting to the Chief Executive Officer of the Company. Executive agrees to perform all duties and responsibilities traditionally assigned to, or falling within the normal responsibilities of, an individual employed as Senior Vice President, Administration and Chief Human Resources Officer of the Company. Executive also agrees to perform any and all additional duties or responsibilities consistent with such position as may be assigned by the Board of Directors or the Chief Executive of the Company in its or his sole discretion.
|
2.
|
Efforts and Duty of Loyalty
. During the term of employment with the Company, Executive covenants and agrees to exercise reasonable efforts to perform all assigned duties in a diligent and professional manner and in the best interest of the Company. Executive agrees to devote his full working time, attention, talents, skills and efforts to further the Company’s business interests. Executive agrees not to engage in any outside business activity, whether or not pursued for gain, profit or other pecuniary advantage, without the express written consent of the Company. Executive shall act at all times in accordance with the Company’s Code of Ethical Business Conduct, and all other applicable policies which may exist or be adopted by the Company from time to time. The Executive may serve on other boards of directors as shall not interfere with the proper performance of his duties and obligations hereunder consistent with the Company’s Corporate Governance Standards for Board of Directors and applicable laws, with the prior consent of the Company.
|
3.
|
At-Will Employment
. Subject to the terms and conditions set forth below, Executive specifically acknowledges and accepts such employment on an “at-will” basis and agrees that both Executive and the Company retain the right to terminate this relationship at any time, with or without cause, for any reason not prohibited by applicable law upon notice as required by this Agreement. Executive acknowledges that nothing in this Agreement is intended to create, nor should be interpreted to create, an employment contract for any specified length of time between the Company and Executive.
|
4.
|
Compensation
. For all services rendered by Executive on behalf of, or at the request of, the Company, in his capacity as Senior Vice President, Administration and Chief Human Resources Officer of the Company, Executive shall be compensated as follows from and after the Start Date, subject to withholding for payment of any and all applicable federal, state and local payroll and withholding taxes.
|
|
(a)
|
Base Salary
. For the services performed by him under this Agreement, the Company shall pay Executive a base salary of Four Hundred Twenty Five Thousand Dollars ($425,000) per year, pro-rated for the period which Executive serves (“Base Salary”). The Base Salary shall be paid in the same increments as the Company’s normal payroll, but no less frequently than monthly and prorated for any period less than a full month. Executive’s Base Salary shall be reviewed at least annually, with the initial review taking place during the fourth quarter of 2016.
|
|
(b)
|
STIC Bonus
. Incentive compensation, payable solely at the discretion of the Board of Directors of the Company, pursuant to the Company’s existing Incentive Compensation Program or any other program as the Company may establish from time to time in its sole discretion. For each fiscal year, the annual performance bonus target will be not less than 60% of base salary earned during such fiscal year. Bonus will be based upon the performance measure and objectives established by the Board from time to time, but ultimately subject to the Compensation and Management Development Committee’s (“CMDC”) discretion. Minimum bonus will be 0% of target and maximum bonus will be 200% of target.
|
|
(c)
|
Long-Term Incentive Plan
. The Executive will be eligible to participate in the long-term incentive plan in place at the time and as authorized by the CMDC, at the time of the normal equity grant, with the first year’s target value of 175% of base salary. The Award is expected to be comprised of stock options, restricted stock units and performance shares, in combination or exclusively, realizing the proportional mix may change over time in consultation with the Executive and the Board.
|
|
(d)
|
Sign On Equity Grant
. Executive shall receive a one-time award in the amount of One Million Two Hundred Fifty Thousand Dollars ($1,250,000.00), comprised of Restricted Stock Units, vesting in equal amounts on an annual basis over three years from the date of award. Following the Start Date, Executive will be provided with a Hill-Rom Holdings, Inc. award agreement providing the terms and additional details regarding Executive’s one time award.
|
|
(e)
|
Intentionally Omitted
|
|
(f)
|
Retirement Plans
. Commencing on the Start Date, Executive will be entitled to participate in Company retirement plans (e.g., 401(k) Savings Plan and Supplemental Executive Retirement Plan) consistent with plans, programs or policies available to other senior executive officers of the Company and subject to satisfaction of any applicable eligibility requirements.
|
|
(g)
|
Other Benefits
.
Commencing
on the Start Date, Executive will be entitled to participate in and receive such additional benefits and perquisites, including health and welfare benefits (such as a Company-paid Executive physical examination) as are available to other senior executives of the Company and as the Board of Directors of Company may deem appropriate and as pre-approved by the Compensation and Management Development Committee of the Board. Executive will be entitled to 26 days of paid time off.
|
5.
|
Changes to Compensation
.
Notwithstanding anything contained herein to the contrary, Executive acknowledges that the Company specifically reserves the right to make changes to Executive’s compensation in its sole discretion including, but not limited to, modifying or eliminating a compensation component. The Parties agree that such changes shall be deemed effective immediately and a modification of this Agreement unless, within thirty (30) days after receiving notice of such change, Executive exercises his right to terminate this Agreement without cause or for “Good Reason,”
in the event Executive is not treated in a manner that is commensurate with the treatment of other senior executives of the Company, if applicable, as provided below in Paragraphs Nos. 9 and 11.
|
6.
|
Direct Deposit
. As a condition of employment, and within thirty (30) days of the Start Date of this Agreement, Executive agrees to make all necessary arrangements to have all sums paid pursuant to this Agreement direct deposited into one or more bank accounts as designated by Executive.
|
7.
|
Predecessor Employers
. Except as otherwise disclosed in writing to the Compensation Committee of the Board prior to the date hereof Executive warrants that he is not a party to any contract, restrictive covenant, or other agreement purporting to limit or otherwise adversely affecting his ability to secure employment with any third party. Alternatively, should any such agreement exist, Executive warrants that the contemplated services to be performed hereunder will not violate the terms and conditions of any such agreement.
|
8.
|
Restricted Duties
. Executive agrees not to disclose, or use for the benefit of the Company, any confidential or proprietary information belonging to any predecessor employer(s) that otherwise has not been made public and further acknowledges that the Company has specifically instructed him not to disclose or use such confidential or proprietary information. Based on his understanding of the anticipated duties and responsibilities hereunder, Executive acknowledges that such duties and responsibilities will not compel the disclosure or use of any such confidential and proprietary information.
|
9.
|
Termination Without Cause
. The Parties agree that either party may terminate this employment relationship at any time, without cause, upon sixty (60) days’ advance written notice or, if terminated by the Company, pay in lieu of notice (hereinafter referred to as “notice pay”). In such event, Executive shall only be entitled to such compensation, benefits and perquisites that have been paid or fully accrued as of the effective date of his separation and as otherwise explicitly set forth in this Agreement. However, in no event shall Executive be entitled to notice pay if Executive is eligible for and accepts severance payments pursuant to the provisions of Paragraphs 16 and 17, below. Notice pay shall be paid as if the Executive remained on payroll, subject to Paragraph 14 hereof.
|
10.
|
Termination With Cause
. Executive’s employment may be terminated by the Company at any time “for cause” without notice or prior warning. For purposes of this Agreement, “cause” shall mean the Company’s good faith determination that Executive has:
|
|
(a)
|
Acted with gross neglect or willful misconduct in the discharge of his duties and responsibilities, or refused to follow or comply with the lawful direction of the Board of Directors of the Company, the Chief Executive Officer or the terms and conditions of this Agreement providing such refusal is not based primarily on Executive’s good faith compliance with applicable legal or ethical standards.
|
|
(b)
|
Acquiesced or participated in any conduct that is dishonest, fraudulent, illegal, unethical, involves moral turpitude or is otherwise illegal and involves conduct that has the potential, in the Board of Directors’ reasonable opinion, to cause the Company, its officers or its directors significant embarrassment or ridicule;
|
|
(c)
|
Violated a material requirement of any Company policy or procedure, specifically including a violation of the Company’s Code of Ethics or Associate Policy Manual;
|
|
(d)
|
Disclosed without proper authorization any trade secrets or other Confidential Information (as defined herein);
|
|
(e)
|
Engaged in any act that, in the reasonable opinion of the Board of Directors of the Company would hold the Company, its officers or directors up to probable civil or criminal liability, provided that, if Executive acts in good faith for compliance with applicable legal or ethical standards, such actions shall not be grounds for termination for cause;
|
|
(f)
|
Breached the warranties of Executive set forth in Paragraph 7 herein; or
|
|
(g)
|
Engaged in such other conduct recognized at law as constituting cause.
|
11.
|
Termination by Executive for Good Reason
. Executive may terminate his employment and declare this Agreement to have been terminated “without cause” by the Company (and, therefore, for “Good Reason”) upon the occurrence, without Executive’s consent, of any of the following circumstances:
|
|
(a)
|
The assignment to Executives of duties that are materially inconsistent with Executive’s position as Senior Vice President, Administration and Chief Human Resources Officer;
|
|
(b)
|
The failure to elect or reelect Executive as Senior Vice President, Administration and Chief Human Resources Officer of the Company (unless such failure is related in any way to the Company’s decision to terminate Executive for cause);
|
|
(c)
|
A reduction by the Company in the amount of Executive’s base salary or the discontinuation or reduction by the Company of Executive’s participation at previously existing levels of eligibility in any incentive compensation, additional compensation or equity programs, benefits, policies or perquisites; provided, however, that the Company may make such changes and/or reductions without implicating the provisions of this subsection (c) so long as Executive is treated in a manner that is commensurate with the treatment of other senior executives of the Company;
|
|
(d)
|
A failure by the Company to perform its obligations under this Employment Agreement, which, in each of subsections (a) through (d) above, is not remedied by the Company within thirty (30) days of receipt of written notice of such event or breach delivered by Executive to the Company within ninety (90) days of the occurrence of the event. Any termination of employment by the Executive shall be within sixty (60) days of the end of the cure period.
|
12.
|
Termination Due to Death or Disability
. In the event Executive dies or suffers a disability (as defined herein) during the term of employment, this Agreement shall automatically be terminated on the date of such death or disability without further obligation on the part of the Company other than the Accrued Obligations (as defined in Section 10) except that Executive will be immediately vested in the Supplemental Executive Retirement Plan, which shall be paid in accordance with the award agreements, benefits plans, past practice and applicable law. For purposes of this Agreement, Executive shall be considered to have suffered a “disability”: (i) upon a good faith determination by Company that, as a result of any mental or physical impairment, Executive is and will likely remain unable to perform the essential functions of his duties or responsibilities hereunder on a full-time basis for one hundred eighty (180) days, with or without reasonable accommodation, or (ii) Executive becomes eligible for or receives any benefits pursuant to the Company’s long-term disability policy. Notwithstanding anything expressed or implied above to the contrary, the Company agrees to fully comply with its obligations under the Family and Medical Leave Act of 1993 and the Americans with Disabilities Act as well as any other applicable federal, state, or local law, regulation, or ordinance governing the provision of leave to individuals with serious health conditions or the protection of individuals with disabilities as well as the Company’s obligation to provide reasonable accommodation thereunder.
|
13.
|
Reaffirmation
. Upon termination of Executive’s employment for any reason, Executive agrees, if requested to reaffirm in writing his post-employment obligation as set forth in this Agreement.
|
14.
|
Code Section 409A Notification
. Executive acknowledges that he has been advised of the American Jobs Creation Act of 2004, which includes Internal Revenue Code Section 409A, and the regulations and guidance promulgated thereunder (collectively “Code Section 409A”), and which also significantly changed the taxation of nonqualified deferred compensation plans and arrangements.
|
|
(a)
|
The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from, Code Section 409A and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in accordance therewith. If any provision of this Agreement (or of any award of compensation, including equity compensation or benefits) would cause the Executive to incur any additional tax or interest under Code Section 409A, the Company shall, after consulting with the Executive, reform such provision to try to comply with Code Section 409A through good faith modifications to the minimum extent reasonably appropriate to conform with Code Section 409A. To the extent that any provision hereof is modified in order to comply with Code Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to the Executive and the Company of the applicable provision without violating the provisions of Code Section 409A.
|
|
(b)
|
A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment that are considered “nonqualified deferred compensation” under Code Section 409A unless such termination is also a “separation from service” within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of employment” or like terms shall mean “separation from service.” If the Executive is deemed on the date of termination to be a “specified employee” within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any payment that is considered non-qualified deferred compensation under Code Section 409A payable on account of a “separation from service,” and with regard to which an exemption from such section does not apply, such payment or benefit shall be made or provided at the date which is the earlier of (A) the expiration of the six (6)-month period measured from the date of such “separation from service” of the Executive, and (B) the date of the Executive’s death (the “Delay Period”). Upon the expiration of the Delay Period, all payments and benefits delayed pursuant to this Section 14 (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to the Executive in a lump sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein.
|
|
(c)
|
With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Code Section 409A, (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, provided that the foregoing clause (ii) shall not be violated without regard to expenses reimbursed under any arrangement covered by Internal Revenue Code Section 105(b) solely because such expenses are subject to a limit related to the period the arrangement is in effect and (iii) such payments shall be made on or before the last day of Executive’s taxable year following the taxable year in which the expense occurred.
|
|
(d)
|
For purposes of Code Section 409A, the Executive’s right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. In no event may the Executive, directly or indirectly, designate the calendar year of any payment to be made under this Agreement that is considered nonqualified deferred compensation. In no event shall the timing of Executive’s execution of the Separation and Release Agreement, directly or indirectly, result in the Executive designating the calendar year of payment, and if a payment that is subject to execution of the Separation and Release Agreement could be made in more than one taxable year, payment shall be made in the later taxable year.
|
15.
|
Code Section 409A Acknowledgement
. Executive acknowledges that, notwithstanding anything contained herein to the contrary, both Parties shall be independently responsible for assessing their own risks and liabilities under Code Section 409A that may be associated with any payment made under the terms of this Agreement or any other arrangement which may be deemed to trigger Code Section 409A. Further, the Parties agree that each shall independently bear responsibility for any and all taxes, penalties or other tax obligations as may be imposed upon them in their individual capacity as a matter or law.
|
16.
|
Severance Payments
. In the event Executive’s employment is terminated by the Company without cause (including by Executive for Good Reason), and subject to the normal terms and conditions imposed by the Company as set forth herein and in the attached Separation and Release Agreement (Exhibit A), Executive shall be eligible to receive severance pay based upon his base salary at the time of termination for a period of twelve (12) months. Executive will be immediately vested in the Supplemental Executive Retirement Plan. Additionally, the Company shall arrange for the Executive to continue to participate (through COBRA or otherwise), on substantially the same terms and conditions as in effect for the Executive (including any required active employee contribution) immediately prior to such termination, in the health and similar welfare benefits provided to the Executive until the earlier of (i) the end of the 12 month period beginning on the effective date of the termination of Executive’s employment hereunder, or (ii) such time as the Executive is eligible to be covered by comparable benefits of a subsequent employer. The Executive agrees to notify the Company promptly if and when he begins employment with another employer and if and when he becomes eligible to participate in any health or welfare plans of another employer. The foregoing severance rights and obligations shall not exist if Executive voluntarily leaves the Company’s employ without “Good Reason” (as defined above) or is terminated for “cause” (as defined above).
|
17.
|
Severance Payment Terms and Conditions
. No severance pay shall be paid if Executive voluntarily leaves the Company’s employ without Good Reason, as defined above, or is terminated for cause. Any severance pay made payable under this Agreement shall be paid in lieu of, and not in addition to, any other contractual, notice or statutory pay or other accrued compensation obligation (excluding accrued wages and deferred compensation). Additionally, such severance pay is contingent upon Executive materially complying with the restrictive covenants contained herein and executing a Separation and Release Agreement in a form not substantially different from that attached as Exhibit A. Further, the Company’s obligation to provide severance hereunder shall be deemed null and void should Executive fail or refuse to execute and deliver to the Company the Company’s then-standard Separation and Release Agreement (without modification, and which shall not include any restrictive covenants not contained herein and shall not change the Company’s indemnification/liability insurance obligations set forth herein or elsewhere) within any time period as may be prescribed by law or, in absence thereof, twenty-one (21) days after the Executive’s Effective Termination Date. Except as required by Code Section 409A, the above severance pay shall be paid in accordance with the Company’s standard payroll practices (e.g. bi-weekly), except no payment shall be made until after the Separation and Release Agreement becomes effective and the first payment thereafter shall include any missed payment. Notwithstanding the foregoing, if any execution and revocation period overlap two calendar years, payments will be paid in the second (2
nd
) calendar year. Amounts that are nonqualified deferred compensation under Code Section 409A that would otherwise be payable during the six (6) month period immediately following termination shall be paid, with interest, settled, made, or provided, on the expiration of the Delay Period. Notwithstanding, the foregoing Section is subject to the provisions of Code Section 409A.
|
18.
|
Assignment of Rights
.
|
|
(a)
|
Copyrights
. Executive agrees that all works of authorship fixed in any tangible medium of expression by him during the term of this Agreement relating to the Company’s business (“Works”), either solely or jointly with others, shall be and remain exclusively the property of the Company. Each such Work created by Executive is a “work made for hire” under the copyright law and the Company may file applications to register copyright in such Works as author and copyright owner thereof. If, for any reason, a Work created by Executive is excluded from the definition of a “work made for hire” under the copyright law, then Executive does hereby assign, sell, and convey to the Company the entire rights, title, and interests in and to such Work, including the copyright therein, to the Company. Executive will execute any documents that the Company deems necessary in connection with the assignment of such Work and copyright therein. Executive will take whatever steps and do whatever acts the Company requests, including, but not limited to, placement of the Company’s proper copyright notice on Works created by Executive to secure or aid in securing copyright protection in such Works and will assist the Company or its nominees in filing applications to register claims of copyright in such Works. The Company shall have free and unlimited access at all times to all Works and all copies thereof and shall have the right to claim and take possession on demand of such Works and copies.
|
|
(b)
|
Inventions
. Executive agrees that all discoveries, concepts, and ideas, whether patentable or not, including, but not limited to, apparatus, processes, methods, compositions of matter, techniques, and formulae, as well as improvements thereof or know-how related thereto, relating to any present or prospective product, process, or service of the Company (“Inventions”) that Executive conceives or makes during the term of this Agreement relating to the Company’s business, shall become and remain the exclusive property of the Company, whether patentable or not, and Executive will, without royalty or any other consideration:
|
|
(i)
|
Inform the Company promptly and fully of such Inventions by written reports, setting forth in detail the procedures employed and the results achieved;
|
|
(ii)
|
Assign to the Company all of his rights, title, and interests in and to such Inventions, any applications for United States and foreign Letters Patent, any United States and foreign Letters Patent, and any renewals thereof granted upon such Inventions;
|
|
(iii)
|
Assist the Company or its nominees, at the expense of the Company, to obtain such United States and foreign Letters Patent for such Inventions as the Company may elect; and
|
|
(iv)
|
Execute, acknowledge, and deliver to the Company at the Company’s expense such written documents and instruments, and do such other acts, such as giving testimony in support of his inventorship, as may be necessary in the opinion of the Company, to obtain and maintain United States and foreign Letters Patent upon such Inventions and to vest the entire rights and title thereto in the Company and to confirm the complete ownership by the Company of such Inventions, patent applications, and patents.
|
19.
|
Company Property
. All records, files, drawings, documents, data in whatever form, business equipment (including computers, PDAs, cell phones, etc.), and the like relating to, or provided by, the Company shall be and remain the sole property of the Company. Upon termination of employment, Executive shall immediately return to the Company all such items without retention of any copies and without additional request by the Company. De minimis items such as pay stubs, 401(k) plan summaries, employee bulletins, and the like are excluded from this requirement. Executive may retain his address books to the extent they only contain contact information.
|
20.
|
Confidential Information
. Executive acknowledges that the Company and its affiliated entities (herein collectively referred to as “Companies”) possess certain trade secrets as well as other confidential and proprietary information which they have acquired or will acquire at great effort and expense. Such information may include, without limitation, confidential information, whether in tangible or intangible form, regarding the Companies’ products and services, marketing strategies, business plans, operations, costs, current or prospective customer information (including customer identities, contacts, requirements, creditworthiness, preferences, and like matters), product concepts, designs, prototypes or specifications, research and development efforts, technical data and know-how, sales information, including pricing and other terms and conditions of sale, financial information, internal procedures, techniques, forecasts, methods, trade information, trade secrets, software programs, project requirements, inventions, trademarks, trade names, and similar information regarding the Companies’ business(es) (collectively referred to herein as “Confidential Information”). Executive further acknowledges that, as a result of his employment with the Company, Executive will have access to, will become acquainted with, and/or may help develop, such Confidential Information. Confidential Information shall not include information readily available in the public so long as such information was not made available through fault of Executive or wrong doing by any other individual.
|
21.
|
Restricted Use of Confidential Information
. Executive agrees that all Confidential Information is and shall remain the sole and exclusive property of the Company and/or its affiliated entities. Except as may be expressly authorized by the Company in writing, or other than in the course of the Executive’s employment and for the benefit of the Company, Executive agrees not to disclose, or cause any other person or entity to disclose, any Confidential Information to any third party while employed by the Company and for as long thereafter as such information remains confidential (or as limited by applicable law). Further, Executive agrees to use such Confidential Information only in the course of Executive’s duties in furtherance of the Company’s business and agrees not to make use of any such Confidential Information for Executive’s own purposes or for the benefit of any other entity or person. The foregoing shall not apply to information that (a) was known to the public prior to its disclosure to the Executive; (b) becomes generally known to the public subsequent to disclosure to the Executive through no wrongful act of the Executive or any representative of the Executive; or (c) the Executive is required to disclose by applicable law, regulation or legal process (provided that the Executive provides the Company with prior notice of the contemplated disclosure and cooperates with the Company at its expense in seeking a protective order or other appropriate protection of such information).
|
22.
|
Acknowledged Need for Limited Restrictive Covenants
. Executive acknowledges that the Companies have spent and will continue to expend substantial amounts of time, money and effort to develop their business strategies, Confidential Information, customer identities and relationships, goodwill and Executive relationships, and that Executive will benefit from these efforts. Further, Executive acknowledges the inevitable use of, or near-certain influence by his knowledge of, the Confidential Information disclosed to Executive during the course of employment if allowed to compete against the Company in an unrestricted manner and that such use would be unfair and extremely detrimental to the Company. Accordingly, based on these legitimate business reasons, Executive acknowledges each of the Companies’ need to protect their legitimate business interests by reasonably restricting Executive’s ability to compete with the Company on a limited basis.
|
23.
|
Non-Solicitation
. During Executive’s employment and for a period of twenty-four (24) months thereafter, Executive agrees not to directly or indirectly engage in the following prohibited conduct:
|
|
(a)
|
Solicit, offer products or services to, or accept orders for, any Competitive Products or otherwise transact any competitive business on behalf of any Competitor;
|
|
(b)
|
Attempt on behalf of any Competitor to entice or otherwise cause any third party to withdraw, curtail or cease doing business with the Company (or any Affiliate thereof), specifically including customers, vendors, independent contractors and other third party entities;
|
|
(c)
|
Except in the course of the Executive’s employment and for the benefit of the Company, disclose to any person or entity the identities, contacts or preferences of any customers of the Company (or any Affiliate thereof), or the identity of any other persons or entities having business dealings with the Company (or any Affiliate thereof);
|
|
(d)
|
Induce any individual who has been employed by or had provided services to the Company (or any Affiliate thereof) within the six (6) month period immediately preceding the effective date of Executive’s separation to terminate such relationship with the Company (or any Affiliate thereof);
|
|
(e)
|
Assist, coordinate or otherwise offer employment to, accept employment inquiries from, or employ any individual who is or had been employed by the Company (or any Affiliate thereof) at any time within the six (6) month period immediately preceding such offer, or inquiry;
|
|
(f)
|
Communicate or indicate in any way to any customer of the Company (or any Affiliate thereof), prior to formal separation from the Company, any interest, desire, plan, or decision to separate from the Company; other than by way of long term retirement plans; or
|
|
(g)
|
Otherwise attempt on behalf of any Competitor to directly or indirectly interfere with the Company’s business, the business of any of the Companies or their relationship with their employees, consultants, independent contractors or customers.
|
24.
|
Limited Non-Compete
. For the above-stated reasons, and as a condition of employment to the fullest extent permitted by law, Executive agrees during the Relevant Non-Compete Period not to directly or indirectly engage in the following competitive activities:
|
|
(a)
|
Executive shall not have any ownership interest in, work for, advise, consult, or have any business connection or business or employment relationship in any competitive capacity with any Competitor unless Executive provides written notice to the Company of such relationship prior to entering into such relationship and, further, provides sufficient written assurances to the Company’s satisfaction that such relationship will not, jeopardize the Company’s legitimate interests or otherwise violate the terms of this Agreement;
|
|
(b)
|
Executive shall not engage in any research, development, production, sale or distribution of any Competitive Products on behalf of a Competitor;
|
|
(c)
|
Executive shall not market, sell, or otherwise offer or provide any Competitive Products within any Geographic Territory on behalf of a Competitor;
|
|
(d)
|
Executive shall not distribute, market, sell or otherwise offer or provide any Competitive Products to any customer of the Company on behalf of a Competitor.
|
25.
|
Non-Compete Definitions
. For purposes of this Agreement, the Parties agree that the following terms shall apply:
|
|
(a)
|
“Affiliate” includes any parent, subsidiary, joint venture, sister company, or other entity controlled, owned, managed or otherwise associated with the Company;
|
|
(b)
|
“Assigned Customer Base” shall include all accounts or customers formally assigned to Executive within a given territory or geographical area or contacted by him at any time during the eighteen (18) month period preceding Executive’s date of separation;
|
|
(c)
|
“Competitive Products” shall include any product or service that directly or indirectly competes with, is substantially similar to, or serves as a reasonable substitute for, any product or service in research, development or design, or manufactured, produced, sold or distributed by the Company;
|
|
(d)
|
“Competitor” shall mean the list of companies on Exhibit B, which can be changed at any time prior to 90 days before termination of employment by or of Executive by written notice to Executive, so long as the list does not exceed fifteen (15) companies and each of which is a material competitor of the Company.
|
|
(e)
|
“Geographic Territory” shall include any territory in which the Company has provided any services or sold any products at any time during the twenty-four (24) month period preceding Executive’s date of separation;
|
|
(f)
|
“Relevant Non-Compete Period” shall include the period of Executive’s employment with the Company as well as a period of twenty-four (24) months after such employment is terminated, regardless of the reason for such termination provided, however, that this period shall be reduced to the greater of (i) twelve (12) months or (ii) the total length of Executive’s employment with the Company, including employment with any parent, subsidiary or affiliated entity, if such employment is less than twenty-four (24) months;
|
|
(g)
|
“Directly or indirectly” shall be construed such that the foregoing restrictions shall apply equally to Executive whether performed individually or as a partner, shareholder, officer, director, manager, Executive, salesperson, independent contractor, broker, agent, or consultant for any other individual, partnership, firm, corporation, company, or other entity engaged in such conduct.
|
26.
|
Consent to Reasonableness
. In light of the above-referenced concerns, including Executive’s knowledge of and access to the Companies’ Confidential Information, Executive acknowledges that the terms of the foregoing restrictive covenants are reasonable and necessary to protect the Company’s legitimate business interests and will not unreasonably interfere with Executive’s ability to obtain alternate employment. As such, Executive hereby agrees that such restrictions are valid and enforceable, and affirmatively waives any argument or defense to the contrary. Executive acknowledges that this limited noncompetition provision is not an attempt to prevent Executive from obtaining other employment in violation of IC § 22-5-3-1 or any other similar statute. Executive further acknowledges that the Company may need to take action, including litigation, to enforce this limited non-competition provision, which efforts the Parties stipulate shall not be deemed an attempt to prevent Executive from obtaining other employment.
|
27.
|
Survival of Restrictive Covenants
. Executive acknowledges that the above restrictive covenants shall survive the termination of this Agreement and the termination of Executive’s employment for any reason. Executive further acknowledges that any alleged breach by the Company of any contractual, statutory or other obligation shall not excuse or terminate the obligations hereunder or otherwise preclude the Company from seeking injunctive or other relief. Rather, Executive acknowledges that such obligations are independent and separate covenants undertaken by Executive for the benefit of the Company.
|
28.
|
[Intentionally Omitted]
|
29.
|
Post-Termination Notification
. For the duration of his Relevant Non-compete Period or other restrictive covenant period, which ever is longer, Executive agrees to promptly notify the Company no later than five (5) business days of his acceptance of any employment or consulting engagement. Such notice shall include sufficient information to ensure Executive compliance with his non-compete obligations and must include at a minimum the following information: (i) the name of the employer or entity for which he is providing any consulting services; (ii) a description of his intended duties as well as (iii) the anticipated start date. Such information is required to ensure Executive’s compliance with his non-compete obligations as well as all other applicable restrictive covenants. Such notice shall be provided in writing to the Office of Vice President and General Counsel of the Company at 1069 State Road 46 E, Batesville, Indiana 47006. Failure to timely provide such notice shall be deemed a material breach of this Agreement and entitle the Company to return of any severance paid to Executive plus attorneys’ fees. Executive further consents to the Company’s notification to any new employer of Executive’s rights and obligations under this Agreement.
|
30.
|
Scope of Restrictions
. If the scope of any restriction contained in any preceding paragraphs of this Agreement is deemed too broad to permit enforcement of such restriction to its fullest extent, then such restriction shall be enforced to the maximum extent permitted by law, and Executive hereby consents and agrees that such scope may be judicially modified accordingly in any proceeding brought to enforce such restriction.
|
31.
|
Specific Enforcement/Injunctive Relief
. Executive agrees that it would be difficult to measure any damages to the Company from a breach of the above-referenced restrictive covenants, but acknowledges that the potential for such damages would be great, incalculable and irremediable, and that monetary damages alone would be an inadequate remedy. Accordingly, Executive agrees that the Company shall be entitled to immediate injunctive relief against such breach, or threatened breach, in any court having jurisdiction. In addition, if Executive violates any such restrictive covenant, Executive agrees that the period of such violation shall be added to the term of the restriction. In determining the period of any violation, the Parties stipulate that in any calendar month in which Executive engages in any activity in violation of such provisions, Executive shall be deemed to have violated such provision for the entire month, and that month shall be added to the duration of the non-competition provision. Executive acknowledges that the remedies described above shall not be the exclusive remedies, and the Company may seek any other remedy available to it either in law or in equity, including, by way of example only, statutory remedies for misappropriation of trade secrets, and including the recovery of compensatory or punitive damages. Executive further agrees that the Company shall be entitled to an award of all costs and attorneys’ fees incurred by it in any attempt to enforce the terms of this Agreement if the Company prevails.
|
32.
|
Publicly Traded Stock
. The Parties agree that nothing contained in this Agreement shall be construed to prohibit Executive from investing his personal assets in any stock or corporate security traded or quoted on a national securities exchange or national market system provided, however, such investments do not require any services on the part of Executive in the operation or the affairs of the business or otherwise violate the Company’s Code of Ethics.
|
33.
|
Notice of Claim and Contractual Limitations Period
. Executive acknowledges the Company’s need for prompt notice, investigation, and resolution of any claims that may be filed against it due to the number of relationships it has with employees and others (and due to the turnover among such individuals with knowledge relevant to any underlying claim). Accordingly, Executive agrees prior to initiating any litigation of any type (including, but not limited to, employment discrimination litigation, wage litigation, defamation, or any other claim) to notify the Company, within One Hundred and Eighty (180) days after the claim accrued, by sending a certified letter addressed to the Company’s General Counsel setting forth: (i) claimant’s name, address, and phone; (ii) the name of any attorney representing Executive; (iii) the nature of the claim; (iv) the date the claim arose; and (v) the relief requested. This provision is in addition to any other notice and exhaustion requirements that might apply. For any dispute or claim of any type against the Company (including but not limited to employment discrimination litigation, wage litigation, defamation, or any other claim), Executive must commence legal action within the shorter of one (1) year of accrual of the cause of action or such shorter period that may be specified by law.
|
34.
|
Non-Jury Trials
. Notwithstanding any right to a jury trial for any claims, Executive waives any such right to a jury trial, and agrees that any claim of any type (including but not limited to employment discrimination litigation, wage litigation, defamation, or any other claim) lodged in any court will be tried, if at all, without a jury.
|
35.
|
Choice of Forum
. Executive acknowledges that the Company is primarily based in Indiana, and Executive understands and acknowledges the Company’s desire and need to defend any litigation against it in Illinois. Accordingly, the Parties agree that any claim of any type brought by Executive against the Company or any of its employees or agents must be maintained only in a court sitting in Cook County, Illinois, or, if a federal court, the Northern District of Illinois. Executive further understands and acknowledges that in the event the Company initiates litigation against Executive, the Company may need to prosecute such litigation in such state where the Executive is subject to personal jurisdiction. Accordingly, for purposes of enforcement of this Agreement, Executive specifically consents to personal jurisdiction in the State of Illinois.
|
36.
|
Choice of Law
. This Agreement shall be deemed to have been made within the County of Cook, State of Illinois and shall be interpreted and construed in accordance with the laws of the State of Illinois. Any and all matters of dispute of any nature whatsoever arising out of, or in any way connected with the interpretation of this Agreement, any disputes arising out of the Agreement or the employment relationship between the Parties hereto, shall be governed by, construed by and enforced in accordance with the laws of the State of Indiana without regard to any applicable state’s choice of law provisions.
|
37.
|
Titles
. Titles are used for the purpose of convenience in this Agreement and shall be ignored in any construction of it.
|
38.
|
Severability
. The Parties agree that each and every paragraph, sentence, clause, term and provision of this Agreement is severable and that, in the event any portion of this Agreement is adjudged to be invalid or unenforceable, the remaining portions thereof shall remain in effect and be enforced to the fullest extent permitted by law. Further, should any particular clause, covenant, or provision of this Agreement be held unreasonable or contrary to public policy for any reason, the Parties acknowledge and agree that such covenant, provision or clause shall automatically be deemed modified such that the contested covenant, provision or clause will have the closest effect permitted by applicable law to the original form and shall be given effect and enforced as so modified to whatever extent would be reasonable and enforceable under applicable law.
|
39.
|
Assignment-Notices
. The rights and obligations of the Company under this Agreement shall inure to its benefit, as well as the benefit of its parent, subsidiary, successor and affiliated entities, and shall be binding upon the successors and assigns of the Company. This Agreement, being personal to Executive, cannot be assigned by Executive, but his personal representative shall be bound by all its terms and conditions. Any notice required hereunder shall be sufficient if in writing and mailed to the last known residence of Executive or to the Company at its principal office with a copy mailed to the Office of the General Counsel.
|
40.
|
Amendments and Modifications
. Except as specifically provided herein, no modification, amendment, extension or waiver of this Agreement or any provision hereof shall be binding upon the Company or Executive unless in writing and signed by both Parties. The waiver by the Company or Executive of a breach of any provision of this Agreement shall not be construed as a waiver of any subsequent breach. Nothing in this Agreement shall be construed as a limitation upon the Company’s right to modify or amend any of its manuals or policies in its sole discretion and any such modification or amendment which pertains to matters addressed herein shall be deemed to be incorporated herein and made a part of this Agreement.
|
41.
|
Outside Representations
. Executive represents and acknowledges that in signing this Agreement he does not rely, and has not relied, upon any representation or statement made by the Company or by any of the Company’s employees, officers, agents, stockholders, directors or attorneys with regard to the subject matter, basis or effect of this Agreement other than those specifically contained herein.
|
42.
|
Other Remedies
. The Executive agrees to execute and be bound by the terms and conditions of the Company’s Limited Recapture Agreement, and any applicable laws, rules and regulations.
|
43.
|
Voluntary and Knowing Execution
. Executive acknowledges that he has been offered a reasonable amount of time within which to consider and review this Agreement; that he has carefully read and fully understands all of the provisions of this Agreement; and that he has entered into this Agreement knowingly and voluntarily, with the assistance of counsel.
|
44.
|
Liability Insurance
. The Company shall cover the Executive under directors and officers liability insurance both during and, while potential liability exists, after the term of this Agreement in the same amount and to the same extent as the Company covers its other officers and non independent director.
|
45.
|
Entire Agreement
. This Agreement constitutes the entire employment agreement between the Parties hereto concerning the subject matter hereof and shall supersede all prior and contemporaneous agreements between the Parties in connection with the subject matter of this Agreement. Any pre-existing Employment Agreements shall be deemed null and void. Nothing in this Agreement, however, shall affect any separately-executed written agreement addressing any other issues.
|
EXECUTIVE
|
HILL-ROM HOLDINGS, INC.
|
|
|
||
Signed:
/s/ Kenneth F. Meyers
|
By:
/s/ John Greisch
|
|
Printed:
Kenneth F. Meyers
|
Title:
Chief Executive Officer
|
|
Dated:
September 21, 2015
|
Dated:
September 21, 2015
|
1.
|
Executive’s active employment by the Company shall terminate effective [date of termination](Executive’s “Effective Termination Date”). Except as specifically provided by this Agreement, or in any other non-employment agreement that may exist between the Company and Executive, Executive agrees that the Company shall have no other obligations or liabilities to him/her following his/her Effective Termination Date and that his/her receipt of the Severance Benefits provided herein shall constitute a complete settlement, satisfaction and waiver of any and all claims he/she may have against the Company.
|
2.
|
Executive further submits, and the Company hereby accepts, his resignation as an Executive, officer and director, as of his Effective Termination Date for any position he may hold. The Parties agree that this resignation shall apply to all such positions Executive may hold with the Company or any parent, subsidiary or affiliated entity thereof. Executive agrees to execute any documents needed to effectuate such resignation. Executive further agrees to take whatever steps are necessary to facilitate and ensure the smooth transition of his duties and responsibilities to others.
|
3.
|
The Company agrees to provide Executive severance pay on the termination of his employment, as provided for in his Employment Agreement.
|
4.
|
The Company further agrees to provide Executive with limited out-placement counseling with a company of its choice provided that Executive participates in such counseling immediately following termination of employment. Notwithstanding anything in this Section 4 to the contrary, the out-placement counseling shall not be provided after the last day of the second calendar year following the calendar year in which termination of employment occurs.
|
5.
|
As of his/her Effective Termination Date, Executive will become ineligible to participate in the Company’s health insurance program and continuation of coverage requirements under COBRA (if any) will be triggered at that time. The medical insurance provided herein does not include any disability coverage.
|
6.
|
Intentionally omitted
|
7.
|
In exchange for the foregoing Severance Benefits, EMPLOYEE FULL NAME on behalf of himself/herself, his/her heirs, representatives, agents and assigns hereby RELEASES, INDEMNIFIES, HOLDS HARMLESS, and FOREVER DISCHARGES (i) Company Name. (ii) its parent, subsidiary or affiliated entities, (iii) in such capacity, all of their present or former directors, officers, Executives, shareholders, and agents, as well as, (iv) all predecessors, successors and assigns thereof from any and all actions, charges, claims, demands, damages or liabilities of any kind or character whatsoever, known or unknown, which Executive now has or may have had through the effective date of this Agreement.
|
8.
|
Without limiting the generality of the foregoing release, it shall include: (i) all claims or potential claims arising under any federal, state or local laws relating to the Parties’ employment relationship, including any claims Executive may have under the Civil Rights Acts of 1866 and 1964, as amended, 42 U.S.C. §§ 1981 and 2000(e)
et
seq
.; the Civil Rights Act of 1991; the Age Discrimination in Employment Act, as amended, 29 U.S.C. §§ 621
et
seq
.; the Americans with Disabilities Act of 1990, as amended, 42 U.S.C §§ 12,101
et
seq
.; the Fair Labor Standards Act 29 U.S.C. §§ 201
et
seq
.; the Worker Adjustment and Retraining Notification Act, 29 U.S.C. §§ 2101,
et
seq
.; the Sarbanes-Oxley Act of 2002, specifically including the Corporate and Criminal Fraud Accountability Act, 18 U.S.C. §1514,A
et
seq
.; and any other federal, state or local law governing the Parties’ employment relationship; (ii) any claims on account of, arising out of or in any way connected with Executive’s employment with the Company or leaving of that employment; (iii) any claims alleged or which could have been alleged in any charge or complaint against the Company; (iv) any claims relating to the conduct of any Executive, officer, director, agent or other representative of the Company; (v) any claims of discrimination, harassment or retaliation on any basis; (vi) any claims arising from any legal restrictions on an employer’s right to separate its Executives; (vii) any claims for personal injury, compensatory or punitive damages or other forms of relief; and (viii) all other causes of action sounding in contract, tort or other common law basis, including (a) the breach of any alleged oral or written contract, (b) negligent or intentional misrepresentations, (c) wrongful discharge, (d) just cause dismissal, (e) defamation, (f) interference with contract or business relationship or (g) negligent or intentional infliction of emotional distress.
|
9.
|
Executive further agrees and covenants not to sue the Company or any entity or individual subject to the foregoing General Release with respect to any claims, demands, liabilities or obligations release by this Agreement provided, however, that nothing contained in this Agreement shall:
|
|
(a)
|
prevent Executive from filing an administrative charge with the Equal Employment Opportunity Commission or any other federal state or local agency; or
|
|
(b)
|
prevent employee from challenging, under the Older Worker’s Benefit Protection Act (29 U.S.C. § 626), the knowing and voluntary nature of his/her release of any age claims in this Agreement in court or before the Equal Employment Opportunity Commission.
|
10.
|
Notwithstanding his/her right to file an administrative charge with the EEOC or any other federal, state, or local agency, Executive agrees that with his/her release of claims in this Agreement, he/she has waived any right he/she may have to recover monetary or other personal relief in any proceeding based in whole or in part on claims released by him/her in this Agreement. For example, Executive waives any right to monetary damages or reinstatement if an administrative charge is brought against the Company whether by Executive, the EEOC, or any other person or entity, including but not limited to any federal, state, or local agency. Further, with his/her release of claims in this Agreement, Executive specifically assigns to the Company his/her right to any recovery arising from any such proceeding.
|
11.
|
The Parties acknowledge that it is their mutual and specific intent that the above waiver fully complies with the requirements of the Older Workers Benefit Protection Act (29 U.S.C. § 626) and any similar law governing release of claims. Accordingly, Executive hereby acknowledges that:
|
|
(a)
|
He/she has carefully read and fully understands all of the provisions of this Agreement and that He/she has entered into this Agreement knowingly and voluntarily;
|
|
(b)
|
The Severance Benefits offered in exchange for Executive’s release of claims exceed in kind and scope that to which he/she would have otherwise been legally entitled absent the execution of this Agreement;
|
|
(c)
|
Prior to signing this Agreement, Executive had been advised, and is being advised by this Agreement, to consult with an attorney of his/her choice concerning its terms and conditions; and
|
|
(d)
|
He/she has been offered at least
[twenty-one (21)/forty-five (45)]
days within which to review and consider this Agreement.
|
12.
|
The Parties agree that this Agreement shall not become effective and enforceable until the date this Agreement is signed by both Parties or seven (7) calendar days after its execution by Executive, whichever is later. Executive may revoke this Agreement for any reason by providing written notice of such intent to the Company within seven (7) days after he/she has signed this Agreement, thereby forfeiting Executive’s right to receive any Severance Benefits provided hereunder and rendering this Agreement null and void in its entirety.
|
13.
|
The Parties agree that nothing contained herein shall purport to waive or otherwise affect any of Executive’s rights or claims that may arise after he/she signs this Agreement. It is further understood by the Parties that nothing in this Agreement shall affect any rights Executive may have under any Company sponsored Deferred Compensation Program, Executive Life Insurance Bonus Plan, Stock Grant Award, Stock Option Grant, Restricted Stock Unit Award, Pension Plan and/or Savings Plan (
i.e.
, 401(k) plan) provided by the Company as of the date of his/her termination, such items to be governed exclusively by the terms of the applicable agreements or plan documents.
|
14.
|
Similarly, notwithstanding any provision contained herein to the contrary, this Agreement shall not constitute a waiver or release or otherwise affect Executive’s rights with respect to any vested benefits, any rights he/she has to benefits which cannot be waived by law, any coverage provided under any Directors and Officers (“D&O”) policy, any rights Executive may have under any indemnification agreement he/she has with the Company prior to the date hereof, any rights he/she has as a shareholder, or any claim for breach of this Agreement, including, but not limited to the benefits promised by the terms of this Agreement.
|
15.
|
[
Option A
]
Executive acknowledges that his/her termination and the Severance Benefits offered hereunder were based on an individual determination and were not offered in conjunction with any group termination or group severance program and waives any claim to the contrary.
|
16.
|
Executive hereby affirms and acknowledges his/her continued obligations to comply with the post-termination covenants contained in his/her Employment Agreement, including but not limited to, the non-compete, trade secret and confidentiality provisions. Executive acknowledges that a copy of the Employment Agreement has been attached to this Agreement as Exhibit A
[B]
or has otherwise been provided to him/her and, to the extent not inconsistent with the terms of this Agreement or applicable law, the terms thereof shall be incorporated herein by reference. Executive acknowledges that the restrictions contained therein are valid and reasonable in every respect and are necessary to protect the Company’s legitimate business interests. Executive hereby affirmatively waives any claim or defense to the contrary.
|
17.
|
Executive acknowledges that the Company as well as its parent, subsidiary and affiliated companies (“Companies” herein) possess, and he/she has been granted access to, certain trade secrets as well as other confidential and proprietary information that they have acquired at great effort and expense. Such information includes, without limitation, confidential information regarding products and services, marketing strategies, business plans, operations, costs, current or, prospective customer information (including customer contacts, requirements, creditworthiness and like matters), product concepts, designs, prototypes or specifications, regulatory compliance issues, research and development efforts, technical data and know-how, sales information, including pricing and other terms and conditions of sale, financial information, internal procedures, techniques, forecasts, methods, trade information, trade secrets, software programs, project requirements, inventions, trademarks, trade names, and similar information regarding the Companies’ business (collectively referred to herein as “Confidential Information”).
|
18.
|
Executive agrees that all such Confidential Information is and shall remain the sole and exclusive property of the Company. Except as may be expressly authorized by the Company in writing, or as may be required by law after providing due notice thereof to the Company, Executive agrees not to disclose, or cause any other person or entity to disclose, any Confidential Information to any third party for as long thereafter as such information remains confidential (or as limited by applicable law) and agrees not to make use of any such Confidential Information for Executive’s own purposes or for the benefit of any other entity or person. The Parties acknowledge that Confidential Information shall not include any information that is otherwise made public through no fault of Executive or other wrong doing. The foregoing shall not apply to information that the Executive is required to disclose by applicable law, regulation or legal process (provided that the Executive provides the Company with prior notice of the contemplated disclosure and cooperates with the Company at its expense in seeking a protective order or other appropriate protection of such information).
|
19.
|
On or before Executive’s Effective Termination Date or per the Company’s request, Executive agrees to return the original and all copies of all things in his/her possession or control relating to the Company or its business, including but not limited to any and all contracts, reports, memoranda, correspondence, manuals, forms, records, designs, budgets, contact information or lists (including customer, vendor or supplier lists), ledger sheets or other financial information, drawings, plans (including, but not limited to, business, marketing and strategic plans), personnel or other business files, computer hardware, software, or access codes, door and file keys, identification, credit cards, pager, phone, and any and all other physical, intellectual, or personal property of any nature that he/she received, prepared, helped prepare, or directed preparation of in connection with his/her employment with the Company. Nothing contained herein shall be construed to require the return of any non-confidential and de minimis items regarding Executive’s pay, benefits or other rights of employment such as pay stubs, W-2 forms, 401(k) plan summaries, benefit statements, etc. Additionally, Executive may retain his address books to the extent they only contain contact information.
|
20.
|
Executive hereby consents and authorizes the Company to deduct as an offset from the above-referenced severance payments, so long as the deduction is not taken from nonqualified deferred compensation under the definition of Code Section 409A, the value of any Company property not returned or returned in a damaged condition as well as any monies paid by the Company on Executive’s behalf (e.g., payment of any outstanding American Express bill).
|
21.
|
Executive agrees to cooperate with the Company in connection with any pending or future litigation, proceeding or other matter which has been or may be brought against or by the Company before any agency, court, or other tribunal and concerning or relating in any way to any matter falling within Executive’s knowledge or former area of responsibility. Executive agrees to immediately notify the Company, through the Office of the General Counsel, in the event he/she is contacted by any outside attorney (including paralegals or other affiliated parties) with regard to matters related to his employment with the Company unless (i) the Company is represented by the attorney, (ii) Executive is represented by the attorney for the purpose of protecting his/her personal interests or (iii) the Company has been advised of and has approved such contact. Executive agrees to provide reasonable assistance and completely truthful testimony in such matters including, without limitation, facilitating and assisting in the preparation of any underlying defense, responding to discovery requests, preparing for and attending deposition(s) as well as appearing in court to provide truthful testimony. The Company agrees to reimburse Executive for all reasonable out of pocket expenses incurred at the request of the Company associated with such assistance and testimony.
|
22.
|
Executive agrees not to make any written or oral statement that may defame, disparage or cast in a negative light so as to do harm to the personal or professional reputation of (a) the Company, (b) its Executives, officers, directors or trustees or (c) the services and/or products provided by the Company and its subsidiaries or affiliate entities. Similarly, in response to any written inquiry from any prospective employer or in connection with a written inquiry in connection with any future business relationship involving Executive, the Company agrees not to provide any information, and the senior officers shall not make any written or oral statement, that may defame, disparage or cast in a negative light so as to do harm to the personal or professional reputation of Executive. The Parties acknowledge, however, that nothing contained herein shall be construed to prevent or prohibit the Company or the Executive from providing truthful information in response to any court order, discovery request, subpoena or other lawful request, rebutting statements by others or making normal competitive-type statements.
|
23.
|
EXECUTIVE SPECIFICALLY AGREES AND UNDERSTANDS THAT THE EXISTENCE AND TERMS OF THIS AGREEMENT ARE STRICTLY CONFIDENTIAL AND THAT SUCH CONFIDENTIALITY IS A MATERIAL TERM OF THIS AGREEMENT
. Accordingly, except as required by law or unless authorized to do so by the Company in writing, Executive agrees that he/she shall not communicate, display or otherwise reveal any of the contents of this Agreement to anyone other than his/her spouse, legal counsel or financial advisor provided, however, that they are first advised of the confidential nature of this Agreement and Executive obtains their agreement to be bound by the same. The Company agrees that Executive may respond to legitimate inquiries regarding the termination of his/her employment by stating that the Parties have terminated their relationship on an amicable basis and that the Parties have entered into a Confidential Separation and Release Agreement that prohibits him/her from further discussing the specifics of his/her separation. Nothing contained herein shall be construed to prevent Executive from discussing or otherwise advising subsequent employers of the existence of any obligations as set forth in his/her Employment Agreement. Further, nothing contained herein shall be construed to limit or otherwise restrict the Company’s ability to disclose the terms and conditions of this Agreement as may be required by business necessity.
|
24.
|
In the event that Executive breaches or threatens to breach any provision of this Agreement, he/she agrees that the Company shall be entitled to seek any and all equitable and legal relief provided by law, specifically including immediate and permanent injunctive relief. Executive hereby waives any claim that the Company has an adequate remedy at law. In addition, and to the extent not prohibited by law, Executive agrees that the Company shall be entitled to discontinue providing any additional Severance Benefits upon such breach. Executive agrees that the foregoing relief shall not be construed to limit or otherwise restrict the Company’s ability to pursue any other remedy provided by law, including the recovery of any actual, compensatory or punitive damages. Moreover, if Executive pursues any claims against the Company subject to the foregoing General Release, Executive agrees to immediately reimburse the Company for the value of all benefits received under this Agreement to the fullest extent permitted by law.
|
25.
|
Similarly, in the event that the Company breaches or threatens to breach any provision of this Agreement, Executive shall be entitled to seek any and all equitable or other available relief provided by law, specifically including immediate and permanent injunctive relief. In the event Executive is wholly unsuccessful, the Company shall be entitled to an award of its costs and attorneys’ fees.
|
26.
|
Both Parties acknowledge that this Agreement is entered into solely for the purpose of terminating Executive’s employment relationship with the Company on an amicable basis and shall not be construed as an admission of liability or wrongdoing by the Company or Executive, both Parties having expressly denied any such liability or wrongdoing.
|
27.
|
Each of the promises and obligations shall be binding upon and shall inure to the benefit of the heirs, executors, administrators, assigns and successors in interest of each of the Parties.
|
28.
|
The Parties agree that each and every paragraph, sentence, clause, term and provision of this Agreement is severable and that, if any portion of this Agreement should be deemed not enforceable for any reason, such portion shall be stricken and the remaining portion or portions thereof should continue to be enforced to the fullest extent permitted by applicable law.
|
29.
|
This Agreement shall be governed by and interpreted in accordance with the laws of the State of Illinois without regard to any applicable state’s choice of law provisions.
|
30.
|
Executive represents and acknowledges that in signing this Agreement he/she does not rely, and has not relied, upon any representation or statement made by the Company or by any of the Company’s Executives, officers, agents, stockholders, directors or attorneys with regard to the subject matter, basis or effect of this Agreement other than those specifically contained herein.
|
31.
|
This Agreement represents the entire agreement between the Parties concerning the subject matter hereof, shall supersede any and all prior agreements which may otherwise exist between them concerning the subject matter hereof (specifically excluding, however, the post-termination obligations contained in an Executive’s Employment Agreement, any obligations contained in an existing and valid Indemnity Agreement of Change in Control or any obligation contained in any other legally-binding document), and shall not be altered, amended, modified or otherwise changed except by a writing executed by both Parties.
|
1.
|
Employment.
As of the effective date of this Agreement, the Company agrees to employ Employee and Employee agrees to serve as Senior Vice President, Surgical/Respiratory Care. Employee agrees to perform all duties and responsibilities traditionally assigned to, or falling within the normal responsibilities of, an individual employed in the above-referenced position. Employee also agrees to perform any and all additional duties or responsibilities as may be assigned by the Company in its sole discretion. The Parties acknowledge that both this title and the underlying duties may change.
|
2.
|
Best Efforts and Duty of Loyalty.
During the term of employment with the Company, Employee covenants and agrees to exercise reasonable efforts to perform all assigned duties in a diligent and professional manner and in the best interest of the Company. Employee agrees to devote Employee's full working time, attention, talents, skills and best efforts to further the Company's business and agrees not to take any action, or make any omission, that deprives the Company of any business opportunities or otherwise act in a manner that conflicts with the best interest of the Company or is otherwise detrimental to its business. Employee agrees not to engage in any outside business activity, whether or not pursued for gain, profit or other pecuniary advantage, without the express written consent of the Company. Employee shall act at all times in accordance with the Company's Code of Ethical Business Conducts, and all other applicable policies which may exist or be adopted by the Company from time to time.
|
3.
|
At-Will Employment.
Subject to the terms and conditions set forth below, Employee specifically acknowledges and accepts such employment on an "at-will" basis and agrees that both Employee and the Company retain the right to terminate this relationship at any time, with or without cause, for any reason not prohibited by applicable law upon notice as required by this Agreement. Employee acknowledges that nothing in this Agreement is intended to create, nor should be interpreted to create, an employment contract for any specified length of time between the Company and Employee.
|
4.
|
Compensation.
For all services rendered by Employee on behalf of, or at the request of, the Company, Employee shall be paid as follows:
|
|
(a)
|
A base salary at the bi-weekly rate of Thirteen Thousand Four Hundred and Sixty One Dollars and Fifty-Four Cents ($13,462.54), less usual and ordinary deductions;
|
|
(b)
|
Incentive compensation, payable solely at the discretion of the Company, pursuant to the Company's existing Incentive Compensation Program or any other program as the Company may establish in its sole discretion; and
|
|
(c)
|
Such additional compensation, benefits and perquisites as the Company may deem appropriate
|
5.
|
Changes to Compensation.
Notwithstanding anything contained herein to the contrary, Employee acknowledges that the Company specifically reserves the right to make changes to Employee's compensation in its sole discretion including, but not limited to, modifying or eliminating a compensation component. The Parties agree that such changes shall be deemed effective immediately and a modification of this Agreement unless, within seven (7) days after receiving notice of such change, Employee exercises Employee's right to terminate this Agreement without cause or for "Good Reason" as provided below in Paragraph No. 11. The
|
6.
|
Direct Deposit.
As a condition of employment, and within thirty (30) days of the effective date of this Agreement, Employee agrees to make all necessary arrangements to have all sums paid pursuant to this Agreement direct deposited into one or more bank accounts as designated by Employee.
|
7.
|
Warranties and Indemnification.
Employee warrants that Employee is not a party to any contract, restrictive covenant, or other agreement purporting to limit or otherwise adversely affecting Employee's ability to secure employment with any third party. Alternatively, should any such agreement exist, Employee warrants that the contemplated services to be performed hereunder will not violate the terms and conditions of any such agreement. In either event, Employee agrees to fully indemnify and hold the Company harmless from any and all claims arising from, or involving the enforcement of, any such restrictive covenants or other agreements.
|
8.
|
Restricted Duties.
Employee agrees not to disclose, or use for the benefit of the Company, any confidential or proprietary information belonging to any predecessor employer(s) that otherwise has not been made public and further acknowledges that the Company has specifically instructed Employee not to disclose or use such confidential or proprietary information. Based on Employee's understanding of the anticipated duties and responsibilities hereunder, Employee acknowledges that such duties and responsibilities will not compel the disclosure or use of any such confidential and proprietary information.
|
9.
|
Termination Without Cause.
The Parties agree that either party may terminate this employment relationship at any time, without cause, upon sixty (60) days' advance written notice or, if terminated by the Company, pay in lieu of notice (hereinafter referred to as "notice pay"). In such event, Employee shall only be entitled to such compensation, benefits and perquisites that have been paid or fully accrued as of the effective date of Employee's separation and as otherwise explicitly set forth in this Agreement. However, in no event shall Employee be entitled to notice pay if Employee is eligible for and accepts severance payments pursuant to the provisions of Paragraphs 16 and 17, below.
|
10.
|
Termination With Cause.
Employee's employment may be terminated by the Company at any time "for cause" without notice or prior warning. For purposes of this Agreement, "cause" shall mean the Company's good faith determination that Employee has:
|
(a)
|
Acted with gross neglect or willful misconduct in the discharge of his/her duties and responsibilities or refused to follow or comply with the lawful direction of the Board of Directors of the Company or the terms and conditions of this Agreement providing such refusal is not based primarily on Employee's good faith compliance with applicable legal or ethical standards;
|
(b)
|
Acquiesced or participated in any conduct that is dishonest, fraudulent, illegal (at the felony level), unethical, involves moral turpitude or is otherwise illegal and involves conduct that has the potential, in the Company's reasonable opinion, to cause the Company, its officers or its directors embarrassment or ridicule;
|
(c)
|
Violated a material requirement of any Company policy or procedure, specifically including a violation of the Company's Code of Ethics or Associate Policy Manual;
|
(d)
|
Disclosed without proper authorization any trade secrets or other Confidential Information (as defined herein);
|
(e)
|
Engaged in any act that, in the reasonable opinion of the Company, is contrary to its best interests or would hold the Company, its officers or directors up to probable civil or criminal liability, provided that, if Executive acts in good faith in compliance with applicable legal or ethical standards, such actions shall not be grounds for termination for cause; or
|
(f)
|
Engaged in such other conduct recognized at law as constituting cause.
|
11.
|
Termination by Employee for Good Reason.
Employee may terminate this Agreement and declare this Agreement to have been terminated "without cause" by the Company (and, therefore, for "Good Reason") upon the occurrence, without Employee's consent, of any of the following acts by the Company, or failures by the Company to act (each a "Good Reason Condition"), provided (i) the Employee provides written notice to the Company of the occurrence of the Good Reason Condition within ten (10) business days after the Employee has knowledge of the Good Reason Condition; (ii) the Company fails to notify the Employee of the Company's intended method of correction within thirty (30) business days after the Company receives Employee's notice, or the Company fails to correct the Good Reason Condition within thirty (30) business days after such Employee notice; and (iii) the Employee resigns within ten (10) business days after the end of the 30-business-day period specified in (ii):
|
(a)
|
A material diminution in Employee's duties;
|
(b)
|
The failure to elect or reelect Employee as Vice President or other officer of the Company (unless such failure is related in any way to the Company's decision to terminate Employee for cause);
|
(c)
|
The failure of the Company to continue to provide Employee with office space, related facilities and support personnel (including, but not limited to, administrative and secretarial assistance) within the Company's principal executive offices commensurate with his responsibilities to, and position within, the Company;
|
(d)
|
A material reduction by the Company in the amount of Employee's base salary or the discontinuation or material reduction by the Company of Employee's participation at the same level of eligibility as compared to other peer employees in any incentive compensation, additional compensation, benefits, policies or perquisites subject to Employee understanding that such reduction(s) shall be permissible if the change applies in a similar way to other peer level employees;
|
(e)
|
The relocation of the Company's principal executive offices or Employee's place of work to a location requiring a change of more than fifty (50) miles in Employee's daily commute; or
|
(f)
|
Any other action or inaction by the Company that constitutes a material breach of this Employment Agreement.
|
12.
|
Termination Due to Death or Disability.
In the event Employee dies or suffers a disability (as defined herein) during the term of employment, this Agreement shall automatically be terminated on the date of such death or disability without further obligation on the part of the Company other than the payment of Accrued Obligations. For purposes of this Agreement, Employee shall be considered to have suffered a "disability" upon a determination that Employee cannot perform the essential functions of Employee's position as a result of such a disability and the occurrence of one or more of the following events:
|
(a)
|
Employee becomes eligible for or receives any benefits pursuant to any disability insurance policy as a result of a determination under such policy that Employee is permanently disabled;
|
(b)
|
Employee becomes eligible for or receives any disability benefits under the Social Security Act; or
|
(c)
|
A good faith determination by the Company that Employee is and will likely remain unable to perform the essential functions of Employee's duties or responsibilities hereunder on a full-time basis, with or without reasonable accommodation, as a result of any mental or physical impairment.
|
13.
|
Exit Interview.
Upon termination of Employee's employment for any reason, Employee agrees, if requested, to participate in an exit interview with the Company and reaffirm in writing Employee's post-employment obligations as set forth in this Agreement.
|
14.
|
Section 409A Notification.
Employee acknowledges that Employee has been advised of the American Jobs Creation Act of 2004, which added Section 409A to the Internal Revenue Code ("Section 409A"), and significantly changed the taxation of nonqualified deferred compensation plans and arrangements. Under proposed and final regulations as of the date of this Agreement, Employee has been advised that Employee's severance pay and other termination benefits may be treated by the Internal Revenue Service as providing
"nonqualified deferred compensation," and therefore subject to Section 409A. In that event, several provisions in Section 409A may affect Employee's receipt of severance compensation, including the timing thereof. These include, but are not limited to, a provision which requires that distributions to "specified employees" of public companies on account of separation from service may not be made earlier than six (6) months after the effective date of such separation. If applicable, failure to comply with Section 409A can lead to immediate taxation of such deferrals, with interest calculated at a penalty rate and a 20% penalty. As a result of the requirements imposed by the American Jobs Creation Act of 2004, Employee agrees if Employee is a "specified employee" at the time of Employee's termination of employment and if payments in connection with such termination of employment are subject to Section 409A and not otherwise exempt, such payments (and other benefits to the extent applicable) due Employee at the time of termination of employment shall not be paid until a date at least six (6) months after the effective date of Employee's termination of employment ("Employee's Effective Termination Date"). Notwithstanding any provision of this Agreement to the contrary, to the extent that any payment under the terms of this Agreement would constitute an impermissible acceleration of payments under Section 409A or any regulations or Treasury guidance promulgated thereunder, such payments shall be made no earlier than at such times allowed under Section 409A. If any provision of this Agreement (or of any award of compensation) would cause Employee to incur any additional tax or interest under Section 409A or any regulations or Treasury guidance promulgated thereunder, the Company or its successor may reform such provision; provided that it will (i) maintain, to the maximum extent practicable, the original intent of the applicable provision without violating the provisions of Section 409A and (ii) notify and consult with Employee regarding such amendments or modifications prior to the effective date of any such change. Each amount to be paid or benefit to be provided to Employee pursuant to this Agreement, which constitutes deferred compensation subject to Section 409A, shall be construed as a separate identified payment for purposes of Section 409A. To the extent required to avoid an accelerated or additional tax under Section 409A, amounts reimbursed to Employee under this Agreement shall be paid to Employee on or before the last day of the year following the year in which the expense was incurred, the amount of expenses eligible for reimbursement (and in-kind benefits provided to Employee) during any one year may not affect amounts reimbursed or provided in any subsequent tax year, and the right to reimbursement (and in-kind benefits provided to Employee) under this Agreement shall not be subject to liquidation or exchange for another benefit.
|
15.
|
Section 409A Acknowledgement.
Employee acknowledges that, notwithstanding anything contained herein to the contrary, both Parties shall be independently responsible for accessing their own risks and liabilities under Section 409A that may be associated with any payment made under the terms of this Agreement or any other arrangement which may be deemed to trigger Section 409A. Further, the Parties agree that each shall independently bear responsibility for any and all taxes, penalties or other tax obligations as may be imposed upon them in their individual capacity as a matter of law. To the extent applicable, Employee understands and agrees that Employee shall have the responsibility for, and Employee agrees to pay, any and all appropriate income tax or other tax obligations for which Employee is individually responsible and/or related to receipt of any benefits provided in this Agreement. Employee agrees to fully indemnify and hold the Company harmless for any taxes, penalties, interest, cost or attorneys' fee assessed against or incurred by the
|
16.
|
Severance Payments.
In the event Employee's employment is terminated by the Company without cause (including by Employee for Good Reason), and subject to the normal terms and conditions imposed by the Company as set forth herein and in the attached Separation and Release Agreement, Employee shall be eligible to receive severance pay based upon Employee's base salary at the time of termination for a period of twelve (12) months.
|
17.
|
Severance Payment Terms and Conditions.
No severance pay shall be paid if Employee voluntarily leaves the Company's employ without Good Reason, as defined above, or is terminated for cause. Any severance pay made payable under this Agreement shall be paid in lieu of, and not in addition to, any other contractual, notice or statutory pay or other accrued compensation obligation (excluding accrued wages and deferred compensation). Additionally, such severance pay is contingent upon Employee fully complying with the restrictive covenants contained herein and executing a Separation and Release Agreement. Further, the Company's obligation to provide severance hereunder shall be deemed null and void should Employee fail or refuse to execute and deliver to the Company the Company's then-standard Separation and Release Agreement (without modification) within any time period as may be prescribed by law or, in absence thereof, twenty-one (21) days after the Employee's Effective Termination Date. Conditioned upon the execution and delivery of the Separation and Release Agreement as set forth in the prior sentence, Severance pay benefits shall be paid as follows: (i) in one lump sum equivalent to six (6) months' salary on the day following the date which is six (6) months following Employee's Effective Termination Date with any remainder to be paid in bi-weekly installments equivalent to the Employee's salary commencing upon the next regularly scheduled payroll date, if both the severance pay benefit is subject to Section 409A and if Employee is a "specified employee" under Section 409A or (ii) for any severance pay benefits not subject to clause (i), begin upon the next regularly scheduled payroll following the earlier to occur of fifteen (15) days from the Company's receipt of an executed Separation and Release Agreement or the expiration of sixty (60) days after Employee's Effective Termination Date and shall be paid on the Company's regularly scheduled pay dates; provided, however, that if the before-stated sixty (60) day period ends in a calendar year following the calendar year in which the sixty (60) day period commenced, then any benefits not subject to clause (i) shall only begin on the next regularly scheduled payroll following the expiration of sixty (60) days after the Employee's Effective Termination Date. Excluding any lump sum payment due as a result of the application of Section 409A (which shall be paid regardless of reemployment), all other severance payments provided hereunder shall terminate upon reemployment.
|
18.
|
Assignment of Rights.
|
(a)
|
Copyrights.
Employee agrees that all works of authorship fixed in any tangible medium of expression by Employee during the term of this Agreement relating to the Company's business ("Works"), either solely or jointly with others, shall be and remain exclusively the property of the Company. Each such Work created by Employee is a "work made for hire" under the copyright law and the Company may file applications to register copyright in such Works as author and copyright owner thereof. If, for any reason, a Work created by Employee is excluded from the definition of a "work made for hire" under the copyright law, then Employee does hereby assign, sell, and convey to the Company the entire rights, title, and interests in and to such Work, including the copyright therein, to the Company. Employee will execute any documents that the Company deems necessary in connection with the assignment of such Work and copyright therein. Employee will take whatever steps and do whatever acts the Company requests, including, but not limited to, placement of the Company's proper copyright notice on Works created by Employee to secure or aid in securing copyright protection in such Works and will assist the Company or its nominees in filing applications to register claims of copyright in such Works. The Company shall have free and unlimited access at all times to all Works and all copies thereof and shall have the right to claim and take possession on demand of such Works and copies.
|
(b)
|
Inventions.
Employee agrees that all discoveries, concepts, and ideas, whether patentable or not, including, but not limited to, apparatus, processes, methods, compositions of matter, techniques, and formulae, as well as improvements thereof or know-how related thereto, relating to any present or prospective product, process, or service of the Company ("Inventions") that Employee conceives or makes during the term of this Agreement relating to the Company's business, shall become and remain the exclusive property of the Company, whether patentable or not, and Employee will, without royalty or any other consideration:
|
(i)
|
Inform the Company promptly and fully of such Inventions by written reports, setting forth in detail the procedures employed and the results achieved;
|
(ii)
|
Assign to the Company all of Employee's rights, title, and interests in and to such Inventions, any applications for United States and foreign Letters Patent, any United States and foreign Letters Patent, and any renewals thereof granted upon such Inventions;
|
(iii)
|
Assist
the Company or its nominees, at the expense of the Company, to obtain such United States and foreign Letters Patent for such Inventions as the Company may elect; and
|
(iv)
|
Execute, acknowledge, and deliver to the Company at the Company's expense such written documents and instruments, and do such other acts, such as giving testimony in support of Employee's inventorship, as may be necessary in the opinion of the Company, to obtain and maintain United States and foreign Letters Patent upon such Inventions and to vest the entire rights and title thereto in the Company and to confirm the complete ownership by the Company of such Inventions, patent applications, and patents.
|
19.
|
Company Property.
All records, files, drawings, documents, data in whatever form, business equipment (including computers, PDAs, cell phones, etc.), and the like relating to, or provided by, the Company shall be and remain the sole property of the Company. Upon termination of employment, Employee shall immediately return to the Company all such items without retention of any copies and without additional request by the Company.
|
20.
|
Confidential Information.
Employee acknowledges that the Company and its affiliated entities (herein collectively referred to as "Companies") possess certain trade secrets as well as other confidential and proprietary information which they have acquired or will acquire at great effort and expense. Such information may include, without limitation, confidential information, whether in tangible or intangible form, regarding the Companies' products and services, marketing strategies, business plans, operations, costs, current or prospective customer information (including customer identities, contacts, requirements, creditworthiness, preferences, and like matters), product concepts, designs, prototypes or specifications, research and development efforts, technical data and know-how, sales information, including pricing and other terms and conditions of sale, financial information, internal procedures, techniques, forecasts, methods, trade information, trade secrets, software programs, project requirements, inventions, trademarks, trade names, and similar information regarding the Companies' business(es) (collectively referred to herein as "Confidential Information"). Employee further acknowledges that, as a result of Employee's employment with the Company, Employee will have access to, will become acquainted with, and/or may help develop, such Confidential Information. Confidential Information shall not include information readily available in the public so long as such information was not made available through fault of Employee or wrong doing by any other individual.
|
21.
|
Restricted Use of Confidential Information.
Employee agrees that all Confidential Information is and shall remain the sole and exclusive property of the Company and/or its affiliated entities. Except as may be expressly authorized by the Company in writing, Employee agrees not to disclose, or cause any other person or entity to disclose, any Confidential Information to any third party while employed by the Company and for as long thereafter as such information remains confidential (or as limited by applicable law). Further, Employee agrees to use such Confidential Information only in the course of Employee's duties in furtherance of the Company's business and agrees not to make use of any such Confidential Information for Employee's own purposes or for the benefit of any other entity or person.
|
22.
|
Acknowledged Need for Limited Restrictive Covenants.
Employee acknowledges that the Companies have spent and will continue to expend substantial amounts of time, money and effort to develop their business strategies, Confidential Information, customer identities and relationships, goodwill and employee relationships, and that Employee will benefit from these efforts. Further, Employee acknowledges the inevitable use of, or near-certain influence by Employee's knowledge of, the Confidential Information disclosed to Employee during the course of employment if allowed to compete against the Company in an unrestricted manner and that such use would be unfair and extremely detrimental to the Company. Accordingly, based on these legitimate business reasons, Employee acknowledges each of the Companies' need to protect their legitimate business interests by reasonably restricting Employee's ability to compete with the Company on a limited basis.
|
23.
|
Non-Solicitation.
During Employee's employment and for a period of eighteen (18) months thereafter, Employee agrees not to directly or indirectly engage in the following prohibited conduct:
|
(a)
|
Solicit, offer products or services to, or accept orders for, any Competitive Products or otherwise transact any competitive business with, any customer or entity with whom Employee had contact or transacted any business on behalf of the Company (or any Affiliate thereof) during the eighteen (18) month period preceding Employee's date of separation or about whom Employee possessed, or had access to, confidential and proprietary information;
|
(b)
|
Attempt to entice or otherwise cause any third party to withdraw, curtail or cease doing business with the Company (or any Affiliate thereof), specifically including customers, vendors, independent contractors and other third party entities;
|
(c)
|
Disclose to any person or entity the identities, contacts or preferences of any customers of the Company (or any Affiliate thereof), or the identity of any other persons or entities having business dealings with the Company (or any Affiliate thereof);
|
(d)
|
Induce any individual who has been employed by or had provided services to the Company (or any Affiliate thereof) within the six (6) month period immediately preceding the effective date of Employee's separation to terminate such relationship with the Company (or any Affiliate thereof);
|
(e)
|
Assist, coordinate or otherwise offer employment to, accept employment inquiries from, or employ any individual who is or had been employed by the Company (or any Affiliate thereof) at any time within the six (6) month period immediately preceding such offer, or inquiry;
|
(f)
|
Communicate or indicate in any way to any customer of the Company (or any Affiliate thereof), prior to formal separation from the Company, any interest, desire, plan, or decision to separate from the Company; or
|
(g)
|
Otherwise attempt to directly or indirectly interfere with the Company's business, the business of any of the Companies or their relationship with their employees, consultants, independent contractors or customers.
|
24.
|
Limited Non-Compete.
For the above-stated reasons, and as a condition of employment to the fullest extent permitted by law, Employee agrees during the Relevant Non-Compete Period not to directly or indirectly engage in the following competitive activities:
|
(a)
|
Employee shall not have any ownership interest in, work for, advise, consult, or have any business connection or business or employment relationship in any competitive capacity with any Competitor unless Employee provides written notice to the Company of such relationship prior to entering into such relationship and, further, provides sufficient written assurances to the Company's satisfaction that such relationship will not, jeopardize the Company's legitimate interests or otherwise violate the terms of this Agreement;
|
(b)
|
Employee shall not engage in any research, development, production, sale or distribution of any Competitive Products, specifically including any products or services relating to those for which Employee had responsibility for the eighteen (18) month period preceding Employee's date of separation;
|
(c)
|
Employee shall not market, sell, or otherwise offer or provide any Competitive Products within Employee's Geographic Territory (if applicable) or Assigned Customer Base, specifically including any products or services relating to those for which Employee had responsibility for the eighteen (18) month period preceding Employee's date of separation; and
|
(d)
|
Employee shall not distribute, market, sell or otherwise offer or provide any Competitive Products to any customer of the Company with whom Employee had contact or for which Employee had responsibility at any time during the eighteen (18) month period preceding Employee's date of separation.
|
25.
|
Non-Compete Definitions.
For purposes of this Agreement, the Parties agree that the following terms shall apply:
|
(a)
|
"Affiliate" includes any parent, subsidiary, joint venture, or other entity controlled, owned, managed or otherwise associated with the Company;
|
(b)
|
"Assigned Customer Base" shall include all accounts or customers formally assigned to Employee within a given territory or geographical area or contacted by Employee at any time during the eighteen (18) month period preceding Employee's date of separation;
|
(c)
|
"Competitive Products" shall include any product or service that directly or indirectly competes with, is substantially similar to, or serves as a reasonable substitute for, any product or service in research, development or design, or manufactured, produced, sold or distributed by the Company;
|
(d)
|
"Competitor" shall include any person or entity that offers or is actively planning to offer any Competitive Products;
|
(e)
|
"Geographic Territory" shall include any territory formally assigned to Employee as well as all territories in which Employee has provided any services, sold any products or otherwise had responsibility at any time during the eighteen (18) month period preceding Employee's date of separation;
|
(f)
|
"Relevant Non-Compete Period" shall include the period of Employee's employment with the Company as well as a period of eighteen (18) months after such employment is terminated, regardless of the reason for such termination provided, however, that this period shall be reduced to the greater of (i) nine (9) months or (ii) the total length of Employee's employment with the Company, including employment with any parent, subsidiary or affiliated entity, if such employment is less than eighteen (18) months;
|
(g)
|
"Directly or indirectly" shall be construed such that the foregoing restrictions shall apply equally to Employee whether performed individually or as a partner, shareholder, officer, director, manager, employee, salesman, independent contractor, broker, agent, or consultant for any other individual, partnership, firm, corporation, company, or other entity engaged in such conduct.
|
26.
|
Consent to Reasonableness.
In light of the above-referenced concerns, including Employee's knowledge of and access to the Companies' Confidential Information, Employee
acknowledges that the terms of the foregoing restrictive covenants are reasonable and necessary to protect the Company's legitimate business interests and will not unreasonably interfere with Employee's ability to obtain alternate employment. As such, Employee hereby agrees that such restrictions are valid and enforceable, and affirmatively waives any argument or defense to the contrary. Employee acknowledges that this limited non-competition provision is not an attempt to prevent Employee from obtaining other employment in violation of IC §22-5-3-1 or any other similar statute. Employee further acknowledges that the Company may need to take action, including litigation, to enforce this limited non-competition provision, which efforts the Parties stipulate shall not be deemed an attempt to prevent Employee from obtaining other employment.
|
27.
|
Survival of Restrictive Covenants.
Employee acknowledges that the above restrictive covenants shall survive the termination of this Agreement and the termination of Employee's employment for any reason. Employee further acknowledges that any alleged breach by the Company of any contractual, statutory or other obligation shall not excuse or terminate the obligations hereunder or otherwise preclude the Company from seeking injunctive or other relief. Rather, Employee acknowledges that such obligations are independent and separate covenants undertaken by Employee for the benefit of the Company.
|
28.
|
Effect of Transfer.
Subject to the provisions of Paragraph 11 above, Employee agrees that this Agreement shall continue in full force and effect notwithstanding any change in job duties, job titles or reporting responsibilities. Employee further acknowledges that the above restrictive covenants shall survive, and be extended to cover, the transfer of Employee from the Company to its parent, subsidiary, or any other affiliated entity (hereinafter collectively referred to as an "Affiliate") or any subsequent transfer(s) among them. Specifically, in the event of Employee's temporary or permanent transfer to an Affiliate, Employee agrees that the foregoing restrictive covenants shall remain in force so as to continue to protect such company for the duration of the non-compete period, measured from Employee's effective date of transfer to an Affiliate. Additionally, Employee acknowledges that this Agreement shall be deemed to have been automatically assigned to the Affiliate as of Employee's effective date of transfer such that the above-referenced restrictive covenants (as well as all other terms and conditions contained herein) shall be construed thereafter to protect the legitimate business interests and goodwill of the Affiliate as if Employee and the Affiliate had independently entered into this Agreement. Employee's acceptance of Employee's transfer to, and subsequent employment by, the Affiliate shall serve as consideration for (as well as be deemed as evidence of Employee's consent to) the assignment of this Agreement to the Affiliate as well as the extension of such restrictive covenants to the Affiliate. Employee agrees that this provision shall apply with equal force to any subsequent transfers of Employee from one Affiliate to another Affiliate.
|
29.
|
Post-Termination Notification.
For the duration of Employee's Relevant Non-compete Period or other restrictive covenant period, whichever is longer, Employee agrees to promptly notify the Company no later than five (5) business days of Employee's acceptance of any employment or consulting engagement. Such notice shall include sufficient information to ensure Employee compliance with Employee's non-compete obligations and must include at a minimum the following information: (i) the name of the employer or entity for which Employee is providing any consulting services; (ii) a description of Employee's intended duties as well as (iii) the anticipated start date. Such information is required to
ensure Employee's compliance with Employee's non-compete obligations as well as all other applicable restrictive covenants. Such notice shall be provided in writing to the Office of Vice President and General Counsel of the Company at 1069 State Road 46 E, Batesville, Indiana 47006. Failure to timely provide such notice shall be deemed a material breach of this Agreement and entitle the Company to return of any severance paid to Employee plus attorneys' fees. Employee further consents to the Company's notification to any new employer of Employee's rights and obligations under this Agreement.
|
30.
|
Scope of Restrictions.
If the scope of any restriction contained in any preceding paragraphs of this Agreement is deemed too broad to permit enforcement of such restriction to its fullest extent, then such restriction shall be enforced to the maximum extent permitted by law, and Employee hereby consents and agrees that such scope may be judicially modified accordingly in any proceeding brought to enforce such restriction.
|
31.
|
Specific Enforcement/Injunctive Relief.
Employee agrees that it would be difficult to measure any damages to the Company from a breach of the above-referenced restrictive covenants, but acknowledges that the potential for such damages would be great, incalculable and irremediable, and that monetary damages alone would be an inadequate remedy. Accordingly, Employee agrees that the Company shall be entitled to immediate injunctive relief against such breach, or threatened breach, in any court having jurisdiction. In addition, if Employee violates any such restrictive covenant, Employee agrees that the period of such violation shall be added to the term of the restriction. In determining the period of any violation, the Parties stipulate that in any calendar month in which Employee engages in any activity in violation of such provisions, Employee shall be deemed to have violated such provision for the entire month, and that month shall be added to the duration of the non-competition provision. Employee acknowledges that the remedies described above shall not be the exclusive remedies, and the Company may seek any other remedy available to it either in law or in equity, including, by way of example only, statutory remedies for misappropriation of trade secrets, and including the recovery of compensatory or punitive damages. Employee further agrees that the Company shall be entitled to an award of all costs and attorneys' fees incurred by it in any attempt to enforce the terms of this Agreement.
|
32.
|
Publicly Traded Stock.
The Parties agree that nothing contained in this Agreement shall be construed to prohibit Employee from investing Employee's personal assets in any stock or corporate security traded or quoted on a national securities exchange or national market system provided, however, such investments do not require any services on the part of Employee in the operation or the affairs of the business or otherwise violate the Company's Code of Ethics.
|
33.
|
Notice of Claim and Contractual Limitations Period.
Employee acknowledges the Company's need for prompt notice, investigation, and resolution of any claims that may be filed against it due to the number of relationships it has with employees and others (and due to the turnover among such individuals with knowledge relevant to any underlying claim). Accordingly, Employee agrees prior to initiating any litigation of any type (including, but not limited to, employment discrimination litigation, wage litigation, defamation, or any other claim) to notify the Company, within One Hundred and Eighty (180) days after the claim accrued, by sending a certified letter addressed to the Company's General Counsel setting forth: (i) claimant's name, address, and phone; (ii) the name of any attorney (if any) representing Employee; (iii) the nature
of the claim; (iv) the date the claim arose; and (v) the
relief requested. This provision is in addition to any other notice and exhaustion requirements that might apply. For any dispute or claim of any type against the Company (including but not limited to employment discrimination litigation, wage litigation, defamation, or any other claim), Employee must commence legal action within the shorter of one (1) year of accrual of the cause of action or such shorter period that may be specified by law.
|
34.
|
Non-Jury Trials.
Notwithstanding any right to a jury trial for any claims, Employee waives any such right to a jury trial, and agrees that any claim of any type (including but not limited to employment discrimination litigation, wage litigation, defamation, or any other claim) lodged in any court will be tried, if at all, without a jury.
|
35.
|
Choice of Forum. Employee acknowledges that the Company is primarily based in
Indiana, and Employee understands and acknowledges the Company's desire and need to defend any litigation against it in Indiana. Accordingly, the Parties agree that any claim of any type brought by Employee against the Company or any of its employees or agents must be maintained only in a court sitting in Marion County, Indiana, or Ripley County, Indiana, or, if a federal court, the Southern District of Indiana, Indianapolis Division. Employee further understands and acknowledges that in the event the Company initiates litigation against Employee, the Company may need to prosecute such litigation in such state where the Employee is subject to personal jurisdiction. Accordingly, for purposes of enforcement of this Agreement, Employee specifically consents to personal jurisdiction in the State of Indiana as well as any state in which resides a customer assigned to the Employee. Furthermore, Employee consents to appear, upon Company's request and at Employee's own cost, for deposition, hearing, trial, or other court proceeding in Indiana or in any state in which resides a customer assigned to the Employee.
|
36.
|
Choice of Law. This Agreement shall be deemed to have been made within the County
of Ripley, State of Indiana and shall be interpreted and construed in accordance with the laws of the State of Indiana. Any and all matters of dispute of any nature whatsoever arising out of, or in any way connected with the interpretation of this Agreement, any disputes arising out of the Agreement or the employment relationship between the Parties hereto, shall be governed by, construed by and enforced in accordance with the laws of the State of Indiana without regard to any applicable state's choice of law provisions.
|
37.
|
Titles.
Titles are used for the purpose of convenience in this Agreement and shall be ignored in any construction of it.
|
38.
|
Severability. The Parties agree that each and every paragraph, sentence, clause, term and
provision of this Agreement is severable and that, in the event any portion of this Agreement is adjudged to be invalid or unenforceable, the remaining portions thereof shall remain in effect and be enforced to the fullest extent permitted by law. Further, should any particular clause, covenant, or provision of this Agreement be held unreasonable or contrary to public policy for any reason, the Parties acknowledge and agree that such covenant, provision or clause shall automatically be deemed modified such that the contested covenant, provision or clause will have the closest effect permitted by applicable law to the original form and shall be given effect and enforced as so modified to whatever extent would be reasonable and enforceable under applicable law.
|
39.
|
Assignment-Notices.
The rights and obligations of the Company under this Agreement shall inure to its benefit, as well as the benefit of its parent, subsidiary, successor and affiliated entities, and shall be binding upon the successors and assigns of the Company. This Agreement, being personal to Employee, cannot be assigned by Employee, but Employee's personal representative shall be bound by all its terms and conditions. Any notice required hereunder shall be sufficient if in writing and mailed to the last known residence of Employee or to the Company at its principal office with a copy mailed to the Office of the General Counsel.
|
40.
|
Amendments and Modifications.
Except as specifically provided herein, no modification, amendment, extension or waiver of this Agreement or any provision hereof shall be binding upon the Company or Employee unless in writing and signed by both Parties. The waiver by the Company or Employee of a breach of any provision of this Agreement shall not be construed as a waiver of any subsequent breach. Nothing in this Agreement shall be construed as a limitation upon the Company's right to modify or amend any of its manuals or policies in its sole discretion and any such modification or amendment which pertains to matters addressed herein shall be deemed to be incorporated herein and made a part of this Agreement.
|
41.
|
Outside Representations.
Employee represents and acknowledges that in signing this Agreement Employee does not rely, and has not relied, upon any representation or statement made by the Company or by any of the Company's employees, officers, agents, stockholders, directors or attorneys with regard to the subject matter, basis or effect of this Agreement other than those specifically contained herein.
|
42.
|
Voluntary and Knowing Execution.
Employee acknowledges that Employee has been offered a reasonable amount of time within which to consider and review this Agreement; that Employee has carefully read and fully understands all of the provisions of this Agreement; and that Employee has entered into this Agreement knowingly and voluntarily.
|
43.
|
Entire Agreement.
This Agreement constitutes the entire employment agreement between the Parties hereto concerning the subject matter hereof and shall supersede all prior and contemporaneous agreements between the Parties in connection with the subject matter of this Agreement. Any pre-existing Employment Agreements shall be deemed null and void. Nothing in this Agreement, however, shall affect any separately-executed written agreement addressing any other issues (e. g., the Inventions, Improvements, Copyrights and Trade Secrets Agreement, etc.).
|
TAYLOR SMITH
|
HILL-ROM HOLDINGS, INC.
|
Signed:
/s/ Taylor Smith
|
BY: /s/ Michael Oliver |
Printed:
Taylor Smith
|
Title: SVP and Chief HR Officer |
Dated:
October 26, 2013
|
Dated: October 30, 2013 |
·
|
Non-employee directors, other than the Chairman of the Board, shall each receive an annual cash retainer of $65,000 for their service as directors and shall not receive meeting fees for attendance at Board meetings; the Chairman of the Board shall receive an annual cash retainer of $135,000 for service as Chairman of the Board.
|
·
|
Each non-employee director, other than the Chairpersons of each committee, who is a member of the Audit, Compensation and Management Development Committee or Nominating/Corporate Governance, shall receive a $12,500, $7,500 and $5,000 annual retainer, respectively. Notwithstanding the foregoing, for any meeting of an ad hoc Committee of the Board that requires attendance in person or by telephone, the non-employee directors who attend, shall each receive a meeting fee of $1,500.
|
·
|
The Chairpersons of each of the Audit, Compensation and Management Development and Nominating/Corporate Governance Committees shall receive a $25,000, $20,000 and $15,000 annual retainer, respectively.
|
·
|
Non-employee directors who attend meetings of Committees of which they are not members shall receive no fees for their attendance.
|
·
|
Board and Committee retainers shall be paid in quarterly installments (with such quarterly installments to be paid on the first day of each quarter).
|
·
|
Each non-employee director shall be reimbursed for expenses incurred as a result of attendance at Board or Committee meetings.
|
·
|
Each non-employee director shall be awarded, on the first trading day following the close of each annual meeting of the Company’s shareholders, restricted stock units (otherwise known as deferred stock awards) valued at $160,000 on the date of grant under the Corporation’s Stock Incentive Plan; provided that the Chairman of the Board’s annual grant of deferred stock awards shall be valued at $200,000. Each deferred stock award granted to any non-employee director shall be for a number of shares of Common Stock determined by dividing (i) the indicated dollar amount by (ii) the average high and low prices of the Common Stock on the date of grant. Vesting for all such restricted stock units will occur on the later to occur of one year and one day from the date of the grant or the six month anniversary of the date that the applicable director ceases to be a member of the Board.
|
1.
|
I have reviewed this Annual Report on Form 10-K of Hill-Rom Holdings, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
1.
|
I have reviewed this Annual Report on Form 10-K of Hill-Rom Holdings, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|